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ABSTRACT
BEHAVIOR OR DIAGNOSIS? EFFECTS OF IRRITABLE PATIENT BEHAVIOR
AND DIAGNOSTIC LABELS ON MENTAL ILLNESS STIGMA
FEBRUARY 2022
NATHAN R. HUFF, B.A., GONZAGA UNIVERSITY
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Linda M. Isbell
Although research demonstrates significant stigma towards individuals with
mental illness, the relative importance of observed behavior and a psychiatric diagnosis
in eliciting stigma remains poorly understood. Using video vignettes, three experiments
(ns = 195, 749, and 791) examined the effect of irritable (vs. calm) behavior and the
presence (vs. absence) of a psychiatric diagnosis (schizophrenia in Studies 1 and 2;
schizophrenia and depression in Study 3) on attitudinal, emotional, and behavioral
dimensions of stigma towards a fictitious emergency room patient seeking migraine
treatment. In line with labeling theory, irritable behavior resulted in greater blameworthy
attributions for behavior, greater fear and anger, less caring emotions, and lower
perceived warmth. Both a depression and schizophrenia diagnosis elicited stigma by
leading to greater endorsements of other stigmatizing attributions (e.g., substance use) as
a reason for behavior. Irritable behavior and both psychiatric diagnoses resulted in
patients being rated as less predictable and more dangerous, whereas irritable behavior
and schizophrenia only resulted in decreased competence. Irritable behavior and
psychiatric diagnosis also interacted to predict desire for social distance. When calm, a
psychiatric diagnosis predicted greater distance, such that a patient with no label was
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least stigmatized, one with depression was moderately stigmatized, and one with
schizophrenia was most stigmatized. When irritable, the patient elicited a higher desire
for distance regardless of psychiatric diagnosis. Mediational analyses show that when
controlling for behavior, perceived dangerousness and fear mediate the effect of a
diagnosis on desire for distance. In all, results suggest both diagnostic labels and irritable
behavior result in stigma via different attitudinal and emotional mechanisms, and that
individuals with psychiatric diagnoses face stigma even if behaving calmly. By enriching
understanding of the relative importance of irritable behavior and a psychiatric diagnosis
on multiple dimensions of mental illness stigma, this work has implications for antistigma interventions.
Keywords: labeling, mental illness stigma, schizophrenia, depression, person perception,
emotion
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CHAPTER 1
INTRODUCTION
Substantial work has demonstrated a widespread persistence of the stigma around
mental illness and its consequences for people with ill mental health (Hinshaw & Stier,
2008; Sickel et al., 2014). Mental illness stigma, defined as the societal devaluation of
individuals with mental illness, includes unfavorable attitudes and perceptions, negative
emotional reactions, and discriminatory behavioral responses towards individuals
labelled as having a mental illness (Hinshaw, 2009). Stigma adversely impacts the health
and well-being of affected groups via various mechanisms, for example by reducing helpseeking behaviors (e.g., Clement et al., 2015, Corrigan et al., 2014), harming economic
well-being (Sharac, et al., 2009), and restricting employment opportunities (Seeman,
2009; Thornicroft et al., 2009). Further, research has demonstrated that stigma towards
mental illness is pervasive and pernicious, appearing in diverse settings such as work,
daily encounters, and healthcare (Baldwin & Marcus, 2006; Cechnicki et al., 2011;
Markowitz, 1998; Parcesepe & Cabassa, 2013).
Mental illnesses are prevalent in the United States, suggesting that stigma impacts
large groups of people. The National Institute of Mental Health (NIMH) estimates that in
2019, 5.2% of American adults, or 13.1 million people, had severe mental illness, defined
as “a mental, behavioral, or emotional disorder resulting in serious functional
impairment” (U.S. Department of Health and Human Services, 2021). When that
definition is expanded to include any mental illness, NIMH reports that nearly one in five
U.S. adults live with a mental illness, totaling 51.5 million people. Stigma can also exert
negative influences on caregivers and family members of those with mental illness (Shi et
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al., 2019), suggesting that the effects of mental illness stigma are not constrained only to
those with a diagnosis. Due to the severe and continued consequences of mental illness
stigma and the large population upon which it levies its effects, researchers have sought
to understand when and from where stigma arises. In other words, what “signaling
events” precipitate stigmatizing attitudes, emotions, and behaviors towards those with
mental illness?
Psychiatric labels (e.g., mentally ill, schizophrenic, depressed) and symptomatic
behaviors (e.g., atypical or irritable behavior, social skills deficits) are two primary
signaling events that have been shown to relate to mental illness stigma (Corrigan, 2000).
Yet, our understanding of their relative importance, and the potential for these signals to
interact in generating stigma, remains limited. In this thesis, I will review relevant
literature and concepts related to signaling events for mental illness. Through this review,
I will trace the history of labelling theory and identify key limitations of this work. Next,
I will report results from two studies that examine the form of stigma derived from
irritable behavior and a severe psychiatric label (schizophrenia). Following a discussion
of these findings, I will consider the possibility that the stigmatizing consequences of
signaling events (i.e., irritable behavior and diagnostic label) may differ as a function of
diagnosis (no label vs. depression vs. schizophrenia). I then report the results of a third
study that tests this question, and synthesize findings across the three studies.
1.1 Signaling Events for Mental Illness
The public relies on multiple types of signaling events to categorize someone as
having a mental illness. These include a label (e.g., mentally ill, schizophrenic,
depressed), psychiatric symptoms (e.g., atypical or irritable behavior, social skills
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deficits), physical appearance (e.g., hygiene), and context (e.g., observing someone
exiting a treatment clinic). Prior research has shown that observing these signals can lead
to stigmatizing responses including fear, discrimination, and social distance (Corrigan,
2000; Kroska et al., 2014). However, some signals may be more likely to elicit stigma
than others. For example, believing an individual has schizophrenia because they told you
this (i.e., labeling) may induce different levels of stigma than believing they have
schizophrenia because you observed them behave in atypical or erratic ways (i.e.,
inferring).
Debate around the importance of labels and behaviors in signaling mental illness
is longstanding, and research has resulted in conflicting findings (see Link & Phelan,
2017 for a review). Early theoretical work by Scheff (1966) argued that media and other
cultural influences teach members of society from an early age to associate mental illness
labels with deviant behavior. This association becomes relevant to a particular individual
when society labels their behavior symptomatic of persistent mental illness, even if the
behavior is transient. Once given a chronic label, society responds to the individual with
uniform, negative responses, which can result in the labelled individual internalizing the
role of being mentally ill. If this label becomes central to their identity, Scheff argues that
they become a ‘stable’ mentally ill person and that it is difficult for them to shed such a
categorization. Borrowing from classic work on deviance, Scheff labels this process
“Labelling Theory,” and asserts that labeling is “the single most important cause of
careers of residual deviance” (Scheff, 1966, p. 92-93).1
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Following critiques from Gove (1980; 1982) and others, Scheff amends his Labelling Theory in
future editions of his text, Being Mentally Ill: A Sociological Theory, to describe labelling as
“among the most important causes” rather than the “single most important cause” (Scheff, 1999).
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In response to this theoretical claim, researchers pursued empirical evidence.
Using primarily vignette paradigms in which behavior and label were experimentally
manipulated, some scholars suggested that behavior above and beyond a label, results in
stigmatization (Farina, et al., 1973; Gove, 1982). For example, Kirk (1974) used vignettes
and a large sample (n = 864) of community college students to examine whether (a) the
label ascribed for a behavior (mentally ill, wicked, under stress), (b) the severity of the
behavior (normal, moderate, severe), and (c) the individual giving the label (self, family,
‘some people’, psychiatrist) impacted social rejection. He found that more severe
behavior resulted in greater rejection regardless of both the label given for the behavior
and the labeler. In his study, a psychiatric label alone did not increase stigma, leading
Kirk to argue that the influence of labelling in the rejection of the mentally ill may be
greatly exaggerated (Kirk, 1974).2
Alternatively, other researchers found that a psychiatric label can elicit stigma
even if behavior is controlled (see Link et al., 1989 for a review). For example, Socall
and Holtgraves (1992) found in a community-based sample in Indiana that a target with a
mental illness (generalized anxiety disorder, major depression, schizophrenia) evoked
greater stigma than an identically behaving target with a comparable physical condition
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Some have argued, including Scheff himself, that Labelling Theory is not a denotative or
positivist theory, but rather sensitizing in nature (Scheff, 1974). A sensitizing theory is not
necessarily unambiguous, and instead aims to direct attention to new data, re-interpret old data,
and challenge assumptions. Taken as such, the utility of Labelling Theory is not to denote the
exact empirical influence of labels relative to behavior, but instead to “jostle the imagination”
(Scheff, 1974, p. 445). As Scheff puts it, the proper question to ask then is not “whether labelling
theory is literally true, but whether the relevant studies are more consistent with labelling theory
than with its competitor, the medical model” (Scheff, 1974, p. 445). Petrunik (1980) examines
how positivist scholars may have used a singular focus on empiricism to deconstruct a
“sociological strawman”; in other words, how positivists challenged a claim that Scheff himself
was not setting out to defend literally. Alternatively, one could interpret Scheff’s 1974 article as a
‘walking-back’ of theoretical claims that did not withstand closer empirical examination.
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(allergic food reaction, drug reaction to anti-hypertensive medication, brain tumor,
respectively). The more severe illness behaviors also led to greater stigma (i.e.,
schizophrenia/brain tumor was more stigmatized than depression/drug reaction which
was more stigmatized than anxiety/food allergy), but this effect did not interact with
label, suggesting that the two signals may relate to stigma independently.
Consistent with these findings, Modified Labeling Theory (Link et al., 1989)
emerged. A tempering of Scheff’s theory, Modified Labeling Theory stopped short of
claiming that labelling itself can manufacture and perpetuate mental illness, but instead
posited that labels and behaviors can both generate stigma towards those with mental
illness. This stigma is harmful — resulting in devaluation, rejection, and discrimination
— but not necessarily a causal driver of mental illness. Modified Labelling theorists also
suggested that those who are labelled as having a mental illness cope with stigma (which
may or may not be internalized [see Thoits, 2011]), by using secrecy, withdrawal, or
attempts to educate others. Most contemporary work on labelling theory subscribes to
this moderate interpretation of the power of labels and behavior in generating stigma.
However, more work is needed to test the relative importance and potential interactive
effects of these two signaling events, as well as overcome methodological limitations
researchers have identified.
1.2 Methodological Limitations of Past Work
While recent work enriches our understanding of labeling theory using updated
methods and behavioral outcomes (Kroska et al., 2014; Thibodeau & Principino, 2019),
most research suffers from limitations. First, while studies importantly focus on
behavioral manifestations of stigma (e.g., social distance), they often do not measure
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attitudinal or emotional dimensions of the construct (Angermeyer et al., 2010). This may
result in an understanding of stigma akin to a ‘black box’, as stigmatizing behaviors are
identified but not attitudes or emotions that prompt or accompany discrimination
(Hinshaw, 2009). Understanding these components’ relationship to behavior may aid
anti-stigma efforts, as attitude changes can result in behavior change (Sheeran et al.,
2016). Also, including attitudes and emotions lays the groundwork for testing processbased questions. For example, observing symptomatic behavior may elicit fear, which
leads to social distancing, whereas a label in the absence of such behavior may elicit
caring. Before such hypotheses can be tested, an understanding of the links between
stigmatizing attitudes, emotions, and behaviors is needed.
Second, prior experimental work describes behaviors almost exclusively using
written vignettes. As Kirk (1974) noted, this approach may pre-categorize or ‘label’ the
behavior a participant reads about, thereby confounding label and behavior. In other
words, participants who read a description of a target behaving abnormally, irritably, or
disruptively are not evaluating any actual behavior of a target but are instead evaluating
the label assigned to describe that behavior. To address this, video vignettes of
individuals behaving in a realistic setting allow for a stronger behavior manipulation that
captures both verbal and non-verbal cues (Burgoon et al., 2011). Studies have also used
control conditions that omit information about a mental illness (e.g., Farina & Hagelauer,
1975), or explicitly tell participants that the target is normal (e.g., Kirk, 1974). These
experimental conditions may not adequately explain abnormal behavior and can result in
paradoxical written vignettes in which a target is explicitly labelled as normal but then
described as behaving abnormally. These paradoxical vignettes may lead to control

6

conditions being perceived as less believable relative to mental illness label conditions,
making it difficult to ascertain whether the psychiatric label itself, or a feature of the
vignette paradigm leads to findings. To overcome this, Socall and Holtgraves (1992)
suggested using alternative believable explanation conditions that adequately justify
aberrant behavior.
Lastly, a substantial proportion of research in this area has measured public
reactions to vague descriptive labels (e.g., mental patient, mentally ill) rather than
specific diagnoses. This approach may result in imprecise understandings of who
participants think about when evaluating targets, as such terms likely give rise to different
referent groups for different respondents (Phelan et al., 2000). Socall and Holtgraves
(1992) also identified this limitation, and others have acknowledged the need to examine
stigma towards specific illnesses (Hinshaw, 2009). Recent work on Modified Labeling
Theory has largely used specific diagnoses (e.g., Abdullah & Brown, 2020), but little
work has done so with the goal of testing the effects of both aberrant behaviors and
psychiatric diagnoses (e.g., Abdullah & Brown [2020] compared stigma towards different
psychiatric diagnoses among Black Americans but did not manipulate behavior).
1.3 Research Overview
We first present two studies examining the stigmatizing potential of two signaling
events for mental illness: a psychiatric label (i.e., schizophrenia) and emotionally
evocative behavior (i.e., irritability). Study 3 builds upon findings from Studies 1 and 2
by testing two questions. First, does the specific form of stigma elicited by a psychiatric
label differ between schizophrenia and depression? Second, does the relative importance
of psychiatric label and emotionally evocative behavior differ for a patient with
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schizophrenia and a patient with depression with respect to stigma? Literature relevant to
these questions is reviewed in the introduction to Study 3.
To manipulate behavior, I created video recordings of a hospital patient behaving
irritably or calmly; to manipulate diagnosis I inserted information concerning mental
illness into an electronic health record (EHR). A hospital setting was selected because
significant disparities exist for those with mental illness across many healthcare domains
(McGinty et al., 2015). As such, the consequences of being labeled in a healthcare setting
are high, and likely persist past the point of care (Firth et al., 2019). An EHR is also a
common and authoritative place to list a mental illness, so participants should not
necessarily be alerted to my interests.
While stigma intensity varies by diagnosis (Abdullah & Brown, 2020), I limited
the scope of my initial two studies to schizophrenia. Those with schizophrenia are highly
stigmatized and experience particularly severe health disparities. By examining this
potent label, I stringently test Kirk’s (1974) claim that the effect of labels is negligible
relative to behavior. I use adaptations of established attribution, emotion, and behavior
measures to capture various dimensions of stigma. In Study 1, I hypothesized a
schizophrenia diagnosis and irritable behavior would increase blameworthy (i.e., internal)
and stigmatizing attributions for behavior, as well as fear, anger, and desire for distance,
and decrease contextual attributions for behavior and caring emotions. In Study 2, I
sought to replicate my findings in a large population-based sample, capture additional
relevant attitudes, and test whether dangerousness and fear mediate the effect of a
psychiatric label on desire for distance (i.e., stigmatizing behavior).
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CHAPTER 2
STUDY 1
2.1 Study 1 Methods
2.1.1 Participants
Based on a power analysis assuming a small to medium effect (f = .2) set to
achieve 80% power, 200 students at a public university in the Northeast United States
participated for course credit in December 2019. Three were removed due to
experimenter error and two failed one of three attention checks (e.g., indicate the
patient’s chief complaint) resulting in a sample of 195 participants ranging in age from 18
to 28 (Mage = 19.92, SD = 1.55). The sample is 154 (79.0%) females and 38 (19.5%)
males. Two (1.0%) did not provide a gender and one (0.5%) selected ‘Other’. The sample
is 62.6% White, 21.0% Asian, 5.6% Black, 5.1% Mixed Race, 1.5% Hispanic, and 3.1%
Other Race. 176 (90.3%) participants reported knowing “anyone who has ever been
diagnosed or treated for a mental health condition” and 63 (32.3%) reported having “been
diagnosed or treated for a mental health condition themselves.” Participants were
randomly assigned to one of four conditions in a 2 (irritable vs. calm behavior) x 2 (no
psychiatric label vs. schizophrenia label) between-subjects design.
2.1.2 Measures
2.1.2.1 Attributions for Behavior
Attributions for behavior were measured using items adapted from prior measures
(Corrigan et al., 2003; Weiner et al., 2011). Participants were asked, “To what extent do
you think the patient's behavior is due to…” and were given 13 attributions in random
order. Participants responded using continuous unnumbered sliding scales scored from 0

9

(not at all) to 100 (very much). Items were chosen to capture two attribution types
supported by theory (Corrigan et al., 2003): internal attributions (e.g., her personality)
and external attributions (e.g., lack of sleep), and a third relevant to my research:
stigmatizing attributions (e.g., substance use). While this factor structure was based on
existing structures, the selection of specific items was necessarily exploratory, as I sought
to include items specific to this medical context (e.g., pain from the headache). Factor
analysis (Appendix C) supported the presence of three factors, explaining 40.4% of the
variance: blameworthy (i.e., internal) attributions (her mood, her personality, her general
attitude, having a bad day [α = .76]), stigmatizing attributions (a mental disorder,
substance use, hormonal imbalance [α = .74]), and contextual (i.e., external) attributions
(stress, pain, lack of sleep [α = .52]).
Three attributions did not load (< .35) onto a single factor: being at the hospital,
how the doctor is treating them, and being too weak to deal with normal levels of pain.
While the need to drop items, and a low reliability for contextual attributions is
unfortunate, this is not surprising given the exploratory nature of this measure. As all
three contextual attributions were conceptually similar, I used a 3-factor structure (which
replicated in Study 2). Blameworthy and contextual attributions (i.e., categories
established by prior literature), were averaged, and analyzed using factor scores.
Stigmatizing attributions were analyzed separately due to the distinct nature of these
identities.
2.1.2.2 Self-Reported Emotions
On continuous unnumbered sliding scales scored from 0 (not at all) to 100 (very
much), participants indicated the extent to which they felt 21 emotions (Isbell et al.,
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2020) while watching the patient video. Prior work suggests three emotion categories are
relevant to mental illness stigma: fear, anger, and caring emotions (Angermeyer &
Matschinger, 1997; Sadler et al., 2015). As such, subscales were created by averaging
participant responses for fear (afraid, anxious, nervous, unsafe, uneasy [α = .85]), anger
(angry, irritated, frustrated, upset, calm [reversed], relaxed [reversed] [α = .84]), and
caring emotions (desire to help, concerned, sympathetic, engaged, compassionate [α =
.83]). This structure was supported by factor analysis (Appendix C) which also indicated
that five items did not significantly load (< .50) onto a single factor: happy, sad,
apathetic, disinterested, and impatient. Happy and sad were included as filler items.
Disinterest, apathy, and impatience were included with the exploratory hypothesis that
these items reflected an absence of caring. However, these items failed to load together,
and as such were not included in the creation of subscales.
2.1.2.3 Desire for Social Distance
Participants completed a social distance scale (Wark & Galliher, 2007) adapted
from prior work (Link et al., 1987). Items were presented in a fixed order: “How
comfortable would you be…knowing this person went to your school, being in the same
class as this person, sitting next to this person in a lecture, having a conversation with this
person, working on a group project with this person, being roommates with this person,
having a close friend of yours date this person, having a close friend of yours marry this
person” (α = .93). Participants responded on continuous unnumbered sliding scales from
0 (not at all comfortable) to 100 (very comfortable). Consistent with classic (Link et al.,
1987) and recent work (Abdullah & Brown, 2020), each participant’s responses were
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averaged to produce a social distance score. Scores were then subtracted from 100 so
higher values indicate greater desire for distance.
2.1.3 Procedure
Study procedures were reviewed and approved by my university’s Institutional
Review Board (Study Name: “Evaluations and Impressions of Hospital Patients”).
Participants completed the study alone in a quiet room on Qualtrics (Qualtrics, 2011).
After consent, a computer screen instructed all participants to form impressions of a
patient who “is meeting with a doctor in the hospital after having come in with a
complaint” (i.e., an initial visit to the emergency room). Participants were then provided a
brief written description of the patient, reviewed the patient’s EHR, watched a video of
the patient interacting with a doctor, and completed all measures.
The brief description of the patient (Appendix A) appeared directly above the
EHR and described her as “a 22-year-old student…complaining of a severe headache.”
Participants in the ‘no label’ condition were told she was diagnosed with migraines in
2015, and that she “takes medication… but sometimes becomes upset due to the pain.”
Participants in the ‘label’ condition were told she was diagnosed with migraines in 2015
and schizophrenia in 2016, and that she “takes medication… but sometimes hears voices
and becomes upset due to the pain.”
The EHRs (Appendix A) were modeled on EHRs used in real medical contexts.
All EHRs listed ‘headache’ as the patient’s chief complaint and provided information
common on an EHR (e.g., height, weight). All EHRs included a history of migraines, but
participants in the ‘label’ condition received an EHR that included a schizophrenia
diagnosis while those in the ‘no label’ condition did not (i.e., the ‘label’ condition
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included migraines and schizophrenia, the ‘no label’ condition included migraines only).
The schizophrenia diagnosis included a short description of symptoms common to
schizophrenia: delusions and auditory hallucinations, which emerged following a period
of non-adherence to medication and resulted in hospitalization. The schizophrenia
condition also included two medications commonly used to treat schizophrenia: Abilify
and Zyprexa. The symptoms and medications were included to ensure that all participants
had a shared understanding of schizophrenia in this context.
Next, participants watched a 60-second, fixed-shot video of the patient. The
patient, a white female named ‘Jill Buckley,’ sat on an examination table in a hospital
room with equipment (e.g., a blood pressure device) behind her and spoke with an out-offrame male doctor. The videos were filmed in a medical simulation center, and the patient
was portrayed by a paid standardized patient (i.e., actor) employed by the center and used
to train physicians and nurses. Participants in the ‘irritable’ condition saw a video in
which the patient was irritable and upset. She spoke exasperatedly, answered the doctor
defensively, and once raised her voice demanding a note for work. Those in the ‘calm’
condition saw a video in which the same patient was calm, spoke quietly, answered the
doctor politely, and respectfully asked for a work note. The patient sat in the same
location and was filmed from the same angle in both videos, and the conversations were
identical in content and included general health questions (e.g., “Can you describe this
headache in more detail?"). To allow for natural portrayals of behavior, the transcripts
were not identical word-for-word, but followed a script with slight wording differences
between the two conditions (see Appendix A for transcripts). Participants then completed
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all measures in the order presented in the methods, provided demographics, and were
debriefed.
2.2 Study 1 Results
See Table 1 for bivariate correlations. 2 x 2 ANOVAs were conducted to test the
effects of patient behavior and schizophrenia diagnosis on dependent variables. See Table
2 for means by experimental condition.
2.2.1 Attributions for Patient Behavior
As predicted, participants who viewed irritable behavior blamed the patient more
(M = 66.32, SD = 14.25) than those who viewed calm behavior (M = 48.00, SD = 20.32),
F(1, 190) = 52.96, p < .001, partial η2 = .218; all other ps > .20. I analyzed stigmatizing
attribution items separately to examine conceptually distinct cases. Participants were
more likely to attribute behavior to a mental disorder if the patient had schizophrenia (M
= 56.20, SD = 28.19) than if not (M = 21.34, SD = 24.51), F(1, 188) = 83.79, p < .001,
partial η2 = .308. Irritable behavior (M = 42.43, SD = 32.48) was marginally more likely
than calm behavior (M = 35.19, SD = 30.48) to be attributed to a mental disorder, p = .07.
Substance use was also rated as a more likely reason for behavior if the patient had
schizophrenia (M = 26.22, SD = 23.95) than if not (M = 16.47, SD = 20.50), F(1, 190) =
9.32, p = .003, partial η2 = .047, as was hormonal imbalance (with label: M = 34.18, SD =
25.57; without label: M = 25.13, SD = 26.33), F(1, 188) = 5.76, p = .017, partial η2 =
.030; all other ps > .10. No effects emerged for contextual attributions, all ps > .25.
Participants indicated a relatively high endorsement of contextual attributions (MTotal =
70.65, SD = 15.95).
2.2.2 Self-Reported Emotions
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Participants who observed the patient behaving calmly reported more caring
emotions (M = 65.09, SD = 19.52) than those who observed the patient behaving irritably
(M = 58.40, SD = 21.59), F(1, 188) = 5.05, p = .026, partial η2 = .026; all other effects, p
> .37. Conversely, participants reported feeling greater anger if they observed the irritable
patient (M = 46.89, SD = 22.12) rather than the calm patient (M = 31.12, SD = 19.23),
F(1, 187) = 27.69, p < .001, partial η2 = .129; all other effects p > .18. No effects were
observed for fearful emotions, all ps > .26.
2.2.3 Desire for Social Distance
For desire for social distance, I observed an effect of patient behavior F(1, 191) =
26.21, p < .001, partial η2 = .121 and a marginally significant effect of diagnosis, F(1,
191) = 3.55, p = .06, partial η2 = .018, qualified by an interaction, F(1, 191) = 7.74, p =
.006, partial η2 = .03 (Figure 1). A Tukey test revealed that a calm patient without
schizophrenia evoked significantly lower desire for social distance (M = 29.85, SD =
20.69) than each of the other three conditions (calm, with schizophrenia: M = 44.08, SD =
19.87; irritable without schizophrenia: M = 53.95, SD = 20.95; irritable with
schizophrenia: M = 51.21, SD = 23.50; ps < .006), which did not differ significantly from
each other, all ps > .11.
2.3 Study 1 Discussion
Study 1 results provide preliminary support for several of my hypotheses. Firstly,
a schizophrenia diagnosis and irritable behavior interacted to predict a key self-report
measure of behavioral stigma — desire for distance. When a patient did not have
schizophrenia, the amount of social distance desired depended on observed behavior; if
the patient behaved calmly, she did not elicit a desire for distance, but if she behaved
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irritably, she did. If the patient had schizophrenia, she was less likely to be accepted
regardless of her behavior. While a self-report measure, desire for distance is central to
stigma (Link et al., 1987), and these results suggest that even if a person labeled with
schizophrenia acts calmly and displays no symptoms, they may still face stigma and
social isolation.
While both behavior and diagnosis influenced desire for distance, these data
suggest more specific effects on attributions and emotions. A patient’s schizophrenia
label, but not their behavior, was more likely to predict participants’ endorsement of
stereotypically related but distinct stigmatizing attributions (e.g., substance use) as
possible causes for behavior. Participant endorsement for stigmatized identities was
below the scale midpoint, suggesting that they were not seen as likely reasons for
behavior relative to blameworthy or contextual attributions. Yet, associating
schizophrenia with other stigmatized identities may exacerbate stigma via stereotyping.
In contrast, when the patient was irritable rather than calm, participants were more
likely to blame the patient for her behavior, report greater anger, and report reduced
caring emotions. While this work investigates layperson’s attitudes towards hospital
patient behavior, this finding may be consequential for patient care if replicated with a
medical population. Prior literature suggests that fear, anger, and caring emotions
contribute to the emergence of mental illness stigma (Corrigan et al., 2003), but I did not
find evidence that a schizophrenia diagnosis alone alters participants’ emotions. This is
puzzling, as the diagnostic label was related to increased desire for distance (i.e., a selfreported behavioral intention to stigmatize). One reason my measures may not have
captured the effect of a schizophrenia diagnosis on emotion is methodology. Participants
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indicated the extent to which they felt emotion while watching the video, an activity that
prioritizes patient behavior rather than diagnostic label. Study 2 addresses this by asking
participants to report emotions they would feel if they were to interact with the patient
directly.
In sum, Study 1 found that irritable behavior and a schizophrenia diagnosis result
in a greater desire for social distance from a hospital patient but impart more specific
effects on attributions and emotions. I also found scant evidence that participants’
emotions were impacted by a schizophrenia label alone. To further test the relative
importance of label and behavior on attitudes, emotions, and behavioral intentions
towards those with this severe mental illness label I conducted a second study utilizing
the same paradigm, but with several important changes. First, I recruited a larger, older
MTurk sample with a more balanced gender distribution to test these effects outside of a
college student sample. Second, I modified my emotion measures to guide participants to
focus on how they would feel if they were to interact with the patient. Third, drawing
from existing work, I captured perceptions of dangerousness and predictability (Corrigan
et al., 2003), and perceptions of warmth and competence (Fiske et al., 2002). Finally, I
explored whether dangerousness and fear mediate the effect of a schizophrenia label on
desire for distance, as previous work has theorized (Corrigan et al., 2003). Taken
together, Study 2 permits a more robust test of the differential effects of patient behavior
and a schizophrenia diagnosis on stigma components and allows for an examination of
mediational hypotheses.
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CHAPTER 3
STUDY 2
3.1 Study 2 Introduction
For measures included from Study 1, I predicted I would replicate my findings.
By asking participants to report their emotions if they were to interact with the patient, I
predicted both irritable behavior and a schizophrenia diagnosis would result in greater
fear and anger, and diminished caring emotions. In addition, I hypothesized irritable (vs.
calm) behavior and the presence (vs. absence) of a schizophrenia diagnosis would
decrease perceptions of warmth, competence, and predictability, and increase perceived
dangerousness. Finally, I examined two hypotheses grounded in labeling theory
(Corrigan et al., 2003), regarding the mediating role that dangerousness and fear may
play in predicting desire for distance as a function of a diagnosis. I predicted a
schizophrenia diagnosis would be positively related to perceived danger, which would be
positively related to desire for distance. Similarly, I predicted schizophrenia would be
related to a greater desire for distance via a serial mediation whereby a label increases
perceived danger, which increases fear, which increases desire for distance.
3.2 Study 2 Methods
3.2.1 Participants
An a priori power analysis specified to detect the smallest effect of interest in
Study 1 (i.e., social distance interaction) with 80% power, and to power mediation
analyses, indicated I should retain a 548-participant sample. 844 participants were
recruited via Amazon’s Mechanical Turk (MTurk) in October 2020 and were paid $0.80.
Respondents were excluded if they skipped more than 25% of the items (n = 19) or
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incorrectly completed one of three attention checks: indicate the sex (n = 31) and chief
complaint (n = 26) of the patient and select “disagree” on a specific item (n = 19). 749
participants were retained, ranging in age from 18 to 82 (Mage = 41.74, SD = 13.31).
Median household income is $30,000-$50,000 and the sample consists of 446 (59.5%)
females and 293 (39.1%) males. Six (0.8%) did not provide gender and four (0.5%)
selected ‘Other’. The sample is 78.2% White, 9.1% Asian, 7.9% Black, 1.9% Mixed
Race, 2.4% Other, 0.5% Missing. 516 (68.9%) participants reported knowing “anyone
who has ever been diagnosed or treated for a mental health condition” and 186 (24.8%)
reported having “been diagnosed or treated for a mental health condition themselves.”
Participants were randomly assigned to one of four conditions in a 2 (irritable vs. calm
behavior) x 2 (no psychiatric label vs. schizophrenia label) between-subjects design.
3.2.2 Measures
3.2.2.1 Attributions for Behavior
The attribution items were the same as Study 1. Following factor analysis
(Appendix C), the same attribution composite measures from Study 1 were created for
blameworthy (α = .76), and contextual (α = .59) attributions. Despite an acceptable alpha,
stigmatizing attributions (α = .73) were again analyzed separately due to the distinct
nature of these stigmatized identities.
3.2.2.2 Warmth and Competence
Based on prior research (Fiske et al., 2002), participants were asked to rate the
extent to which the patient is warm (warm, friendly, good-natured, honest) and competent
(competent, intelligent, skilled, capable) along unnumbered sliding scales scored from 0
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(not at all) to 100 (very much). The warmth (α = .89) and competence (α = .90) scales
demonstrated high reliability and averages were computed for each subscale.
3.2.2.3 Self-Reported Emotions
The emotion items used in Study 2 were identical to Study 1, but the prompt was
modified to refer to a future interaction with the patient (e.g., “Please indicate the extent
to which you would feel the following emotions if you were to interact with the patient
directly”). Following factor analysis (Appendix C) the same subscales were created for
fear (α = .90), anger (α = .89), and caring emotions (α = .90).
3.2.2.4 Perceived Dangerousness and Predictability
Two items measuring dangerousness and two measuring predictability were
drawn from previous work (Corrigan et al., 2003). On continuous unnumbered sliding
scales from 0 (not at all) to 100 (very much), participants indicated how dangerous the
patient was and how likely it is the patient will do something violent toward others. These
items were averaged (α = .92). For predictability, participants completed two items in the
same response format and scale: how predictable do you think the patient’s behavior is,
and how safe would you feel around this patient. These items were averaged (α = .70).
3.2.2.5 Social Distance Scale
Given the non-college student sample in Study 2, I adapted the social distance
scale used in Study 1 to a professional context (e.g., “How comfortable would you be
working at the same company as this person?”; see Appendix B). The scale demonstrated
excellent reliability (α = .95) and responses were averaged and subtracted from 100.
Higher values indicate greater desire for social distance, as in Study 1.
3.2.3 Procedure
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Study procedures were reviewed and approved by my university’s Institutional
Review Board (Study Name: “Evaluations and Impressions of Hospital Patients 2”).
Participants were routed to a survey built on Qualtrics. The order and content of the EHR
and patient video were identical to Study 1; participants reviewed an EHR with or
without a schizophrenia label and watched a 60-second video in which the patient acted
calmly or irritably. Participants then completed all measures in the order presented in the
methods, provided demographic data, and were debriefed.
3.3 Study 2 Results
See Table 1 for bivariate correlations. 2 x 2 ANOVAs were conducted to test the
effects of patient behavior and schizophrenia diagnosis on dependent variables. See Table
2 for means by experimental condition. Following these analyses, I examined mediations.
3.3.1 Attributions for Patient Behavior
Replicating Study 1, participants who viewed a patient behaving irritably
attributed greater blame to the patient (M = 62.92, SD = 19.71) than those who viewed
the same patient acting calmly (M = 47.37, SD = 21.37), F(1, 745) = 106.99, p < .001,
partial η2 = .126; all other ps > .80. Also in line with Study 1, participants were more
likely to endorse that a patient’s behavior was due to a mental disorder if that patient had
schizophrenia (M = 51.05, SD = 28.54) than if she did not (M = 21.97, SD = 24.76), F(1,
745) = 224.68, p < .001, partial η2 = .232. Further, a patient acting irritably was more
likely to have her behavior attributed to a mental disorder (M = 39.72, SD = 31.07)
compared to that patient acting calmly (M = 32.41, SD = 29.21), F(1, 745) = 13.17, p <
.001, partial η2 = .017. These effects did not interact, p = .31. As in Study 1, participants
were unlikely to endorse substance use as a reason for behavior, but more likely to do so
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if she had schizophrenia (M = 29.47, SD = 26.87) than if she did not (M = 21.38, SD =
24.56), F(1, 745) = 18.38, p = .003, partial η2 = .028. Further, irritable behavior was more
likely to be attributed to substance use (M = 27.85, SD = 27.10) than calm behavior (M =
22.75, SD = 24.62), F(1, 745) = 7.19, p = .007, partial η2 = .010. Similarly, a patient with
schizophrenia was judged to be more likely to be behaving due to a hormonal imbalance
(M = 33.11, SD = 26.41) than a patient without schizophrenia (M = 27.07, SD = 25.37),
F(1, 744) = 10.09, p = .002, partial η2 = .013, all other ps > .20. Lastly, participants were
more likely to endorse contextual attributions for behavior if the patient did not have a
psychiatric diagnosis (M = 67.72, SD = 19.03) than if she did (M = 62.73, SD = 17.33),
F(1, 745) = 13.80, p < .001, partial η2 = .018, all other ps > .25.
3.3.2 Self-Reported Emotions
As in Study 1, participants who viewed calm behavior reported greater caring
emotions when imagining interacting with the patient (M = 75.52, SD = 18.97) than those
who viewed irritable behavior (M = 66.09, SD = 23.27), F(1, 745) = 36.70, p < .001,
partial η2 = .047. Participants who viewed a calm patient also expressed less anger
themselves (M = 24.96, SD = 19.55) as compared to those who viewed an irritable patient
(M = 45.74, SD = 23.48), F(1, 745) = 173.29, p < .001, partial η2 = .189. Participants also
reported less fear when thinking about interacting with the calm patient (M = 21.09, SD =
22.36) as compared to the irritable patient (M = 30.60, SD = 23.05), F(1, 745) = 33.15, p
< .001, partial η2 = .043. No other effects emerged, all ps > .21.
3.3.3 Warmth and Competence
The patient was rated as significantly less warm when behaving irritably (M =
39.76, SD = 20.94) than when behaving calmly (M = 65.33, SD = 17.94), F(1, 745) =
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321.62, p < .001, partial η2 = .302, and marginally less warm if she had schizophrenia (M
= 50.99, SD = 22.36) than if not (M = 53.98, SD = 24.12), F(1, 745) = 3.54, p = .06,
partial η2 = .005. Similarly, the patient was judged to be less competent when irritable (M
= 56.32, SD = 18.89) compared to calm (M = 67.82, SD = 16.42), F(1, 745) = 79.31, p <
.001, partial η2 = .096, and less competent if she had schizophrenia (M = 59.55, SD =
18.14) than if she did not (M = 64.42, SD = 18.75), F(1, 745) = 13.57, p < .001, partial η2
= .018. For both outcomes, these effects did not interact, ps > .80.
3.3.4 Perceived Dangerousness and Predictability
The patient was rated as non-threatening overall, MTotal = 20.88, SD = 22.24. Even
so, the irritable patient was rated as more dangerous (M = 25.88, SD = 23.70) as
compared to the calm patient (M = 15.87, SD = 19.47), F(1, 745) = 41.43, p < .001,
partial η2 = .053. Further, a schizophrenia diagnosis increased dangerousness (M = 25.94,
SD = 23.40) relative to no diagnosis (M = 16.13, SD = 19.99), F(1, 745) = 39.34, p <
.001, partial η2 = .050. When irritable, the patient was judged to be less predictable (M =
56.63, SD = 22.46) than when calm (M = 68.30, SD = 20.21), F(1, 745) = 58.22, p <
.001, partial η2 = .072, and a schizophrenia label decreased perceived predictability (M =
56.83, SD = 21.78) relative to no label (M = 67.74, SD = 21.17), F(1, 745) = 50.54, p <
.001, partial η2 = .064. No interaction emerged for either variable, ps > .20.
3.3.5 Desire for Social Distance
For desire for social distance, a main effect of patient behavior F(1, 745) =
150.82, p < .001, partial η2 = .168 and a main effect of schizophrenia diagnosis F(1, 745)
= 17.57, p < .001, partial η2 = .023 emerged, qualified by a marginally significant
interaction, F(1, 745) = 3.11, p = .08, partial η2 = .004 (Figure 1). While the interaction
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did not reach significance, I held an a priori hypothesis based on Study 1. As such, I
performed a Tukey test to correct for family-wise error and used α = .01 as a significance
threshold (i.e., a double-correction). As in Study 1, a calm patient without schizophrenia
evoked a significantly lower desire for distance (M = 21.92, SD = 21.57) than the same
calm patient with schizophrenia (M = 32.55, SD = 21.98), p < .001. Also replicating
Study 1, an irritable patient evoked a relatively high desire for distance whether they had
schizophrenia (M = 51.31, SD = 26.25) or did not (M = 46.98, SD = 27.27), p = .32. In
contrast to Study 1, a calm patient with schizophrenia elicited a lower desire for distance
than an irritable patient with or without schizophrenia, ps < .001.
3.3.6 Does a Label Increase Social Distance Via Dangerousness and Fear?
After obtaining evidence that a schizophrenia label increases perceived
dangerousness and desire for social distance, I tested my hypothesized mediations. Model
one hypothesized that the presence of a schizophrenia diagnosis increases perceived
danger, which increases desire for social distance, controlling for patient behavior. Model
two hypothesized a serial mediation, in which the presence of schizophrenia, controlling
for patient behavior, increases perceived danger, in turn elevating fear, which predicts
increased desire for social distance. Mediation models were run using Hayes’
PROCESSv3.4 in SPSS with 10,000 bootstrap samples.
Model 1. Dangerousness Mediates the Effect of a Schizophrenia Label on
Desire for Distance. Results were consistent with my mediational hypothesis. Examining
the first step of the mediation model (Figure 2), a schizophrenia label was associated with
a significant increase in perceived dangerousness (b = 9.70, SE = 1.55, p < .001),
controlling for patient behavior. An increase in perceived dangerousness was related to
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an increase in desire for distance (b = 0.54, SE = 0.04, p < .001), controlling for behavior
and diagnosis. As such, the model significantly predicted desire for distance, F(3, 745) =
141.08, p < .001, R2 = .36, and the indirect effect of a diagnosis on desire for distance
through perceived dangerousness, was significant (b = 5.21, SE = 0.94, bootstrapped 95%
CI [3.45, 7.12]). When controlling for behavior and this indirect effect, the direct effect
of a diagnosis on desire for distance was no longer significant (b = 2.26, SE = 1.62, p =
.16).
Model 2. Dangerousness and Fear Mediates the Effect of a Schizophrenia
Label on Desire for Distance. I next examined a serial mediation (Figure 2), in which a
schizophrenia label sequentially predicted dangerousness, fear, and desire for distance,
controlling for patient behavior. Results were also consistent with this mediational model.
Again, a label was associated with an increase in perceived dangerousness (b = 9.70, SE
= 1.55, p < .001). This was associated with greater fear when thinking about interacting
with the patient (b = 0.60, SE = 0.03, p < .001). Finally, greater fear was associated with a
greater desire for distance, controlling for all other predictors (b = 0.16, SE = 0.04, p <
.001). The model significantly predicted desire for distance, F(4, 744) = 111.48, p <
.001, R2 = .37, and the indirect effect of label on distance through dangerousness and
fear, was significant (b = 0.93, SE = 0.32, bootstrapped 95% CI [0.39, 1.66]). When
controlling for behavior and all indirect effects, the effect of a schizophrenia diagnosis on
desire for distance fell to marginal significance (b = 3.01, SE = 1.62, p = .06).
3.4 Study 2 Discussion
Consistent with Study 1 and in a larger, older, population-based sample with a
more balanced gender distribution, I find evidence for discrete effects of a schizophrenia
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diagnosis and irritable behavior on negative attitudes and emotions towards a hospital
patient. Irritable behavior, compared to calm, again resulted in greater blameworthy
attributions for behavior, greater anger, and less caring emotions. Stigmatizing
attributions were again found to be unlikely reasons for behavior, but more likely for
patients with schizophrenia. Also, desire for distance varied as a function of a marginally
significant interaction between patient behavior and schizophrenia diagnosis.
Extending Study 1, perceptions of warmth, competence, dangerousness, and
predictability all varied independently as a function of patient behavior and psychiatric
diagnosis. An irritable patient was rated as less competent, less predictable, more
dangerous, and colder than a calm patient. Similarly, a patient with schizophrenia was
rated as less competent, less predictable, more dangerous, and marginally colder. The
effect sizes of irritable behavior on warmth and competence were much larger than the
effect sizes of a schizophrenia label (provided in the written EHR), indicating that
observed behavior may be more salient than a written diagnosis when assessing warmth
and competence. While the patient was seen as non-threatening and predictable, the effect
sizes for irritable behavior and written label on these judgements were of similar
magnitude. A schizophrenia label and behavior thus appear to levy comparable effects on
dangerousness and predictability, which aligns with work suggesting these judgements
are key precipitants of mental illness stigma (Jorm et al., 2012). These findings enrich
this work by indicating that such appraisals associated with mental illness may emerge in
response to this specific label and irritable behaviors equally.
The importance of perceived dangerousness in generating stigma was further
indicated by mediational analyses. The presence of a schizophrenia diagnosis was
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significantly related to greater perceived dangerousness, which was related to a greater
desire for distance. Similarly, a schizophrenia diagnosis was serially related to greater
perceptions of dangerousness, greater fear, and a greater desire for distance. Crucially,
these indirect effects were significant when controlling for behavior. Because these
measurements are at one timepoint it is impossible to draw causal conclusions, but
findings are consistent with the widely held idea that negative behavioral intentions
manifest as a function of negative attitudes and emotions towards stereotyped groups
generally (Cuddy et al., 2007) and those with mental illness specifically (Corrigan et al.,
2003).
3.4.1 Studies 1 and 2 Limitations
Studies 1 and 2 are not without limitations. First, my EHR manipulation includes
clinical markers (e.g., medications, delusions, hallucinations, medication non-adherence)
that may confound the effect of a label alone. This presentation offers strengths (i.e., realworld validity, participants having a shared understanding of the diagnosis), but these
markers may also serve as alternate explanations for participants’ negative ratings of the
patient. Study 3 attempts to retain the real-world validity of an EHR by keeping
necessary diagnostic symptoms (i.e., delusions, hallucinations), but removing medication
non-adherence from the clinical work-up. Second, Studies 1 and 2 examine schizophrenia
only. It may be that the stigmatizing effects of a written diagnosis on an EHR is
constrained to relatively less common, and stereotypically more severe psychiatric
conditions. Study 3 aims to examine the effects of irritable behavior and diagnostic labels
on stigma toward a relatively more common mental illness diagnosis — depression — as
well as schizophrenia.
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CHAPTER 4
STUDY 3
4.1 Study 3 Introduction
Study 3 builds upon findings from Studies 1 and 2 by investigating two key
questions. First, does the specific form of stigma elicited by a psychiatric label differ
between schizophrenia and depression? Second, does the relative importance of observed
behavior and written diagnosis differ for a patient with schizophrenia versus one with
depression with respect to stigma? Study 3 also removes medication non-adherence from
the schizophrenia and depression EHRs to rule out this information as an explanatory
component of the effects of written diagnosis. Before describing the hypotheses for Study
3, I first review literature relevant to stigma towards schizophrenia and depression.
4.1.1 Stigma Towards Schizophrenia and Depression
Substantial work demonstrates that schizophrenia and depression are psychiatric
labels that elicit different levels of stigma. Compared to individuals with depression,
individuals with schizophrenia evoke a greater desire for social distance (Angermeyer &
Matschinger, 2003; Angermeyer et al., 2004; Crisp et al., 2000; Lauber et al., 2004;
Marie & Miles, 2008; Pescosolido et al., 1999; see Jorm & Oh, 2009 for a review). In
addition to consistent findings suggesting the intensity of stigma (i.e., social distance)
differs between schizophrenia and depression, studies have explored differences in
beliefs, attitudes, and emotions related to stigma towards these labels. Perceived
dangerousness, biological etiology, prognosis, and personal responsibility have all been
identified as relevant dimensions of stigma that may explain differences in social
distance. Individuals with schizophrenia, as compared to those with depression, are
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perceived to be more dangerous (Angermeyer & Matschinger, 2003; Crisp et al., 2000;
Marie & Miles, 2008), more likely to have their condition due to biological etiology
(Angermeyer & Matschinger, 2003; Dietrich et al., 2006; Schomerus et al., 2006), more
likely to have a worse prognosis for their illness (Goerg et al., 2004), and less likely to be
responsible for the onset of their illness (Jorm et al., 1997).
Two studies of note have used mediational analysis to specifically test whether
differences in these beliefs explain differences in social distance from individuals with
schizophrenia and depression. Using written vignettes and a sample of New Zealand
university students, Marie and Miles (2008) found that participants desired greater
distance from individuals with schizophrenia compared to those with depression, and that
greater perceived dangerousness partially mediated this effect.3 Norman et al., (2010)
examined the same question across two studies, and also found that schizophrenia,
relative to depression, elicited a greater desire for social distance. In their studies,
however, analyses implicated beliefs about the likely appropriateness of social behavior
as a mediator of the effect of diagnostic label on desire for distance. Dangerousness only
partially mediated the effect of label on desire for distance in a college age sample (Study
1) and did not do so in a community sample (Study 2). Further, perceived dangerousness
did not vary between depression and schizophrenia in Study 2. This runs counter to the
body of literature reviewed by Jorm et al., (2012) that suggests people with schizophrenia
are more likely to be perceived as dangerous relative to people with depression.
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Marie and Miles (2008) also included substance dependence and alcohol use disorder as vignette
conditions. They found the depression vignette elicited a significantly lower desire for distance than the
schizophrenia, substance dependence, and alcohol use disorder vignettes. Regression analyses found that
greater perceived dangerousness predicted greater desire for distance for all vignettes except the depression
vignette, further suggesting that for depression, dangerousness is less relevant to judgements of social
distance.

29

While extant literature delineates the form and intensity of stigma towards
schizophrenia and depression, it suffers from methodological limitations described in the
introduction. Namely, written vignette studies confound behavior and diagnostic label.
As such, the literature reviewed allows for the formation of clear hypotheses regarding
the impact of diagnostic labels on the form and intensity of stigma but sheds less light on
the relative importance of behavior and label in eliciting stigma across these two labels.
4.1.2 Study 3 Hypotheses
H1: Irritable vs. Calm Behavior. Replicating Studies 1 and 2, I predict irritable
behavior, relative to calm behavior, will result in greater blaming attributions, fear, anger,
and dangerousness, as well as lower caring emotions, warmth, competence, and
predictability, regardless of psychiatric diagnosis.
H2a: Schizophrenia Label vs. No Psychiatric Label. Also replicating Studies 1
and 2, a schizophrenia label relative to no psychiatric label will result in greater
stigmatizing attributions, lower warmth, competence, and predictability, and higher
ratings of perceived dangerousness to oneself and others.
H2b: Depression Label vs. No Psychiatric Label. Extending Study 1 and 2
findings to a novel psychiatric label, I predict that a depression label relative to no
psychiatric label will result in greater stigmatizing attributions, lower warmth,
competence, and predictability, and higher perceived dangerousness to oneself, but not
higher ratings of perceived dangerousness to others (Jorm et al., 2012).
H2c: Schizophrenia Label vs. Depression Label. Based on existing literature, I
hypothesize that a schizophrenia label, relative to a depression label, will result in greater
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stigmatizing attributions, lower warmth, competence, and predictability, and higher
ratings of perceived dangerousness to others (but not to oneself).
H3a: Interaction of Behavior and Label on Desire for Social Distance. As in
Studies 1 and 2, a psychiatric label and irritable behavior are hypothesized to interact to
predict desire for social distance. The nature of this interaction is unclear, however, as my
prior studies only investigate schizophrenia, and written vignette studies are unable to
tease apart the contributions of labeling and behavior. Nonetheless, I predict that the
interaction present in Study 2 for schizophrenia will be replicated for depression. An
irritable patient — regardless of psychiatric label — will elicits a high desire for distance,
whereas desire for social distance from a calm patient will vary as a function of
diagnostic label, such that a calm patient with no psychiatric label is least stigmatized,
one with depression is moderately stigmatized, and one with schizophrenia is highly
stigmatized.
H3b: Dangerous Mediates the Effect of a Schizophrenia (But Not Depression)
Label on Desire for Distance. I hypothesize that dangerousness and fear, as in Study 2,
will mediate the effect of a schizophrenia label on desire for social distance. I expect that
this mediational pathway will not remain significant for a depression label.
4.2 Study 3 Methods
4.2.1 Participants
An a priori power analysis specified to detect the smallest effect of interest in
Study 2 (i.e., social distance interaction) with 80% power, and to power mediation
analyses, indicated I should retain a 700-participant sample. 823 participants were
recruited via MTurk in October 2021 and were paid $0.80. Respondents were excluded if
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they skipped over 25% of the items (n = 1), requested their data be excluded (n = 4), or
failed one of three attention checks: indicate the patient’s sex (n = 5) and chief complaint
(n = 10) and select “disagree” on a specific item (n = 12). 791 participants were retained,
ranging in age from 19 to 81 (Mage = 42.05, SD = 13.68). Median household income is
$50,000-$70,000 and the sample consists of 543 (68.6%) females and 241 (30.5%) males.
Four participants (0.5%) indicated they were non-binary, two (0.2%) provided other
gender identities, and one (0.1%) did not provide gender information. The sample is
79.3% White, 8.5% Black, 5.1% Asian, 4.3% Mixed Race, 2.1% Other, and 0.7% chose
not to respond. 609 (77.0%) participants reported knowing “anyone who has ever been
diagnosed or treated for a mental health condition” and 324 (41.0%) reported having
“been diagnosed or treated for a mental health condition themselves.” Participants were
randomly assigned to one of six conditions in a 2 (calm vs. irritable behavior) x 3 (no
psychiatric label vs. depression label vs. schizophrenia label) between-subjects design.
4.2.2 Measures
The attribution, warmth, competence, self-reported emotions, perceived
dangerousness, predictability, and social distance scales were identical to those used in
Study 2. Two additional items capturing dangerousness to oneself were adapted from the
dangerousness items used in Study 2: “How dangerous do you think this patient is to
herself?” and “How likely is it that this patient would do something harmful to herself?”
Both items were scored on unnumbered sliding scales scored from 0 (Not dangerous at
all/Not at all likely), to 100 (Very dangerous/Very likely). In line with Studies 1 and 2,
composite scores were created for blameworthy attributions (α = .77), contextual
attributions (α = .60), warmth (α = .87), competence (α = .87), fear (α = .89), anger (α =
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.89), caring emotions (α = .90), dangerousness to others (α = .91), predictability (α = .60),
and desire for distance (α = .96) by averaging participant responses to items in each
factor. Also consistent with Studies 1 and 2, stigmatizing attributions (e.g., substance use,
hormonal imbalance, a mental disorder) were analyzed separately. A composite score
was created for dangerousness to self by averaging participant responses to the two new
items (α = .96). See Appendix B for all study measures.
4.2.3 Procedure
Study procedures were reviewed and approved by my university’s Institutional
Review Board (Study Name: “Evaluations and Impressions of Hospital Patients 2”). The
procedure for Study 3 closely followed Studies 1 and 2 but included six experimental
conditions in a 2 (calm vs. irritable behavior) x 3 (no psychiatric label vs. depression
label vs. schizophrenia label) between-subjects experimental design. In addition, minor
changes were made to the stimulus materials. Participants were routed from the MTurk
platform to a survey created in Qualtrics. After consent, participants were randomly
assigned to review a patient description and EHR that included a diagnosis of migraines
only (no psychiatric label condition), a diagnosis of depression and migraines (depression
label condition), or a diagnosis of schizophrenia and migraines (schizophrenia label
condition). As in Studies 1 and 2, the brief description of the patient (Appendix A)
appeared directly above the EHR and described her as “a 22-year-old student…
complaining of a severe headache.” Participants in the ‘no label’ condition were told she
was diagnosed with migraines in 2017, and that she “takes medication… but sometimes
becomes upset due to the pain.” Participants in the ‘schizophrenia label’ condition were
told she was diagnosed with migraines in 2017 and schizophrenia in 2018, and that she
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“takes medication… but sometimes hears voices and becomes upset due to the pain.”
Participants in the ‘depression label’ condition were told she was diagnosed with
migraines in 2017 and depression in 2018, and that she “takes medication… but
sometimes has a depressed mood and becomes upset due to the pain.”
Identical in format to those used in Studies 1 and 2, the EHRs (Appendix A) listed
‘headache’ as the patient’s chief complaint and provided the same information common
on an EHR (e.g., height, weight). All EHRs included a history of migraines, but
participants in the ‘schizophrenia label’ condition and the ‘depression label’ condition
received an EHR that included a schizophrenia diagnosis and a depression diagnosis
respectively, while those in the ‘no label’ condition did not. Like Studies 1 and 2, the
schizophrenia diagnosis included a short description of symptoms common to
schizophrenia: delusions and auditory hallucinations. Unlike Studies 1 and 2, the EHR
did not include a period of non-adherence to medication. The schizophrenia condition
also included only one medication (rather than two, as in Studies 1 and 2) commonly
used to treat schizophrenia: Abilify. Non-adherence was removed to ensure it did not
explain the effects of a schizophrenia label on attitudes in Studies 1 and 2 and the second
medication was removed to ensure that the total number of medications in the
schizophrenia and depression condition was equal. The depression diagnosis included a
short description of symptoms common to depression: a depressed mood and fatigue. The
depression condition also included one medication commonly used to treat depression:
Celexa. The symptoms and medications were included to ensure that participants had a
shared understanding of schizophrenia and depression in this context.
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Next, participants watched a video of the patient behaving calmly or irritably.
Videos were identical to Studies 1 and 2 (see Appendix A for transcripts). Participants
then completed all patient judgement measures in the order presented in the methods,
provided demographics, and were debriefed.
4.3 Study 3 Results
See Table 1 for bivariate correlations. 2 (calm vs. irritable behavior) x 3 (no
psychiatric label vs. depression label vs. schizophrenia label) ANOVAs were conducted
to examine effects of patient behavior and psychiatric label on outcomes of interest. See
Table 2 for means by experimental condition. For significant main effects of psychiatric
label, follow-up comparisons were conducted by selecting relevant cases to test for
differences between marginal means (e.g., no psychiatric label, depression,
schizophrenia). When a significant interaction was observed, planned contrasts were used
to examine the effect of psychiatric labels in the presence and absence of irritable
behavior. Finally, hypothesized mediation models were examined. See Table S6
(Appendix C) for a summary of results from all three studies.
4.3.1 Attributions for Patient Behavior
Blameworthy Attributions. Consistent with Studies 1 and 2, participants were
more likely to blame the patient for her behavior if she was irritable (M = 65.97, SD =
19.69) than if she was calm (M = 47.02, SD = 20.99), F(1, 785) = 171.08, p < .001,
partial η2 = .179, all other ps > .45.
Stigmatizing Attributions. Irritable patient behavior (M = 41.77, SD = 31.05)
was also more likely than calm behavior (M = 30.39, SD = 27.64) to be attributed to a
mental disorder, F(1, 784) = 36.18, p < .001, partial η2 = .044. Belief that the patient’s
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behavior was due to a mental disorder also varied as a function of her psychiatric
diagnosis, F(2, 784) = 79.79, p < .001, partial η2 = .169. These effects did not interact,
F(2, 784) = 0.24, p = .78, partial η2 = .001. Follow-up analyses indicated the patient with
no psychiatric diagnosis was less likely to have her behavior attributed to a mental
disorder (M = 19.55, SD = 22.57) than both the patient with depression (M = 40.29, SD =
29.17), F(1, 522) = 86.35, p < .001, partial η2 = .142, and the patient with schizophrenia
(M = 48.10, SD = 29.85), F(1, 522) = 162.32, p < .001, partial η2 = .237. Further,
schizophrenia resulted in significantly higher mental disorder attributions compared to
depression, F(1, 524) = 9.89, p = .002, partial η2 = .019.
Similarly, participants were more likely to endorse substance use as a reason for
behavior if the patient was irritable (M = 26.98, SD = 27.08) than if the patient was calm
(M = 19.59, SD = 23.42), F(1, 785) = 17.15, p < .001, partial η2 = .021. Substance use
attributions also varied significantly as a function of psychiatric diagnosis, F(2, 785) =
5.95, p = .003, partial η2 = .015, and did not interact with patient behavior, F(2, 785) =
1.49, p = .23, partial η2 = .004. Similar to mental disorder attributions, the patient’s
behavior was rated as less likely to be due to substance use if she had no psychiatric
diagnosis (M = 19.12, SD = 23.42) compared to both an identical patient with depression
(M = 26.58, SD = 27.87), F(1, 523) = 11.22, p = .001, partial η2 = .021, and an identical
patient with schizophrenia (M = 23.99, SD = 24.65), F(1, 522) = 5.66, p = .018, partial η2
= .011. Unlike mental disorder attributions, substance use attributions did not differ
between the depression and schizophrenia conditions, F(1, 525) = 1.22, p = .27, partial η2
= .002.
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Lastly, irritable behavior resulted in greater attributions to hormonal imbalance
(M = 31.08, SD = 27.21) compared to calm behavior (M = 26.17, SD = 24.45), F(1, 785)
= 7.24, p = .007, partial η2 = .009. Attributions to hormonal imbalance also differed as a
function of psychiatric diagnosis, F(2, 785) = 3.91, p = .02, partial η2 = .010. These
effects did not interact, F(2, 785) = 1.45, p = .24, partial η2 = .004. Similar to substance
use and mental disorder attributions, the behavior of a patient with no psychiatric
diagnosis was rated as less likely to be due to hormonal imbalance (M = 25.04, SD =
24.57) than both an identical patient with depression (M = 31.06, SD = 26.68), F(1, 523)
= 7.28, p = .007, partial η2 = .014, and an identical patient with schizophrenia (M =
29.65, SD = 26.26), F(1, 522) = 4.41, p = .036, partial η2 = .008. Like substance use,
hormonal imbalance attributions for patients with depression and schizophrenia were not
significantly different from one another, F(1, 525) = 0.35, p = .55, partial η2 = .001.
Contextual Attributions. As in Studies 1 and 2, contextual attributions did not
vary as a function of behavior, diagnosis, or an interaction of these factors, all ps > .31.
4.3.2 Self-Reported Emotions
Anger. Participant anger differed as a function of patient behavior, F(1, 784) =
240.38, p < .001, partial η2 = .235, and psychiatric diagnosis, F(2, 784) = 4.54, p = .01,
partial η2 = .011, but these main effects were qualified by a two-way interaction, F(2,
784) = 3.93, p = .02, partial η2 = .010 (Figure 3). When the patient was irritable, a
schizophrenia label reduced anger (M = 40.80, SD = 23.08) compared to no label (M =
49.26, SD = 22.85), t(256.92) = 2.97, p = .003, partial η2 = .033, and compared to a
depression label (M = 47.34, SD = 22.59), t(258.49) = 2.31, p = .02, partial η2 = .020,
which did not differ from one another, t(259.81) = 0.69, p = .49, partial η2 = .002. When
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the patient was calm, a schizophrenia label had the same effect on anger (M = 22.49, SD
= 15.22) as no label (M = 21.32, SD = 16.96), t(260.08) = 0.59, p = .56, partial η2 =
.001). However, a calm patient with depression elicited significantly more anger (M =
26.34, SD = 20.00) than a calm patient without a label, t(256.78) = 2.20, p = .029, partial
η2 = .018 and marginally more anger than a calm patient with schizophrenia, t(246.56) =
1.77, p = .078, partial η2 = .012.
Fear. Participants reported feeling greater fear when they imagined interacting
with an irritable patient (M = 29.25, SD = 22.66) as compared to a calm patient (M =
18.19, SD = 20.42), F(1, 784) = 52.18, p < .001, partial η2 = .062. Fear also differed as a
function of psychiatric diagnosis, F(2, 784) = 3.60, p = .03, partial η2 = .009, which did
not interact with patient behavior, F(2, 784) = 1.27, p = .28, partial η2 = .003. Imagining
interacting with a patient with depression elicited greater fear (M = 26.58, SD = 23.58)
than with a patient with no label (M = 22.36, SD = 21.70), F(1, 523) = 4.83, p = .03,
partial η2 = .009, or a patient with schizophrenia (M = 22.02, SD = 21.16), F(1, 524) =
5.51, p = .02, partial η2 = .010. As in Studies 1 and 2, fear did not differ between the no
label and schizophrenia conditions, F(1, 521) = 0.03, p = .87, partial η2 < . 001.
Caring. Also in line with Studies 1 and 2, participants reported greater caring
emotions if asked to imagine interacting with a calm patient (M = 77.38, SD = 18.26) as
compared to an irritable patient (M = 65.80, SD = 22.83), F(1, 784) = 62.32, p < .001,
partial η2 = 0.74, all other ps > .18.
4.3.3 Warmth and Competence
Warmth. Replicating Study 2, the patient was rated as significantly less warm
when behaving irritably (M = 38.06, SD = 17.98) than when behaving calmly (M = 64.24,

38

SD = 17.38), F(1, 785) = 435.74, p < .001, partial η2 = .357. The effect of psychiatric
diagnosis on warmth was non-significant, F(2, 785) = 2.40, p = .09, partial η2 = .006, and
did not interact with patient behavior, F(2, 785) = 1.77, p = .17, partial η2 = .004.
Competence. An irritable patient was judged to be less competent (M = 56.97, SD
= 17.25) than her identical, calm counterpart (M = 66.90, SD = 15.62), F(1, 784) = 72.98,
p < .001, partial η2 = .085. Competence also varied as a function of diagnosis, F(2, 784)
= 4.48, p = .01, partial η2 = .011, and these effects did not interact, F(2, 784) = 0.83, p =
.44, partial η2 = .002. Replicating Study 2, a patient with schizophrenia was perceived to
be less competent (M = 59.74, SD = 17.18) than a patient with no label (M = 63.93, SD =
17.09), F(1, 521) = 8.88, p = .003, partial η2 = .017. A patient with a depression label,
however, was rated as similarly competent (M = 62.29, SD = 17.06) to a patient with no
label, F(1, 523) = 1.28, p = .26, partial η2 = .002, but marginally more competent than a
patient with schizophrenia, F(1, 524) = 3.33, p = .069, partial η2 = . 006.
4.3.4 Perceived Dangerousness and Predictability
Dangerousness to Others. Dangerousness to others differed as a function of
patient behavior, F(1, 785) = 76.98, p < .001, partial η2 = .089, and psychiatric diagnosis,
F(2, 785) = 18.51, p < .001, partial η2 = .045, but was qualified by a significant two-way
interaction, F(2, 785) = 3.03, p = .05, partial η2 = .008 (Figure 4). When the patient was
calm, perceived dangerousness without a psychiatric label (M = 6.50, SD = 12.60) was
lower than schizophrenia (M = 15.92, SD = 18.05), t(239.91) = 4.95, p < .001, partial η2
= .084, and depression (M = 13.17, SD = 17.89) t(237.28) = 3.51, p = .001, partial η2 =
.045, which did not differ from one another, t(265.99) = 1.25, p = .21, partial η2 = .006.
When the patient was irritable, perceived dangerousness without a psychiatric label (M =
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20.32, SD = 22.43) was statistically similar to depression (M = 20.76, SD = 22.86),
t(260.00) = 0.15, p = .88, partial η2 < .001, and schizophrenia was rated as more
dangerous (M = 31.59, SD = 23.02) than both no psychiatric label, t(256.71) = 3.99, p <
.001, partial η2 = .058, and depression t(258.77) = 3.81, p < .001, partial η2 = .053.
Dangerousness to Self. Irritable patients were rated as more likely to be a danger
to themselves (M = 31.60, SD = 25.74) compared to calm patients (M = 22.28, SD =
22.22), F(1, 785) = 33.75, p < .001, partial η2 = .041. Perceptions of dangerousness to
oneself also varied as a function of psychiatric diagnosis, F(2, 785) = 44.56, p < .001,
partial η2 = .102, which did not interact with behavior, F(2, 785) = 1.61, p = .20, partial
η2 = .004. A patient without a psychiatric diagnosis was perceived to be significantly less
likely to be a danger to herself (M = 16.93, SD = 20.65) than a patient with depression (M
= 28.16, SD = 24.77), F(1, 523) = 33.04, p < .001, partial η2 = .059, and a patient with
schizophrenia (M = 35.49, SD = 24.14), F(1, 522) = 96.33, p < .001, partial η2 = .156. A
patient with schizophrenia was also rated as more likely to be a danger to herself than a
patient with depression, F(1, 525) = 12.55, p < .001, partial η2 = .023.
Predictability. A patient behaving irritably was perceived to be less predictable
(M = 56.63, SD = 21.74) relative to a patient behaving calmly (M = 69.00, SD = 18.50),
F(1, 785) = 80.27, p < .001, partial η2 = .093. Predictability also varied as a function of
psychiatric diagnosis, F(2, 785) = 26.51, p < .001, partial η2 = .063, and did not interact
with behavior, F(2, 785) = 0.81, p = .45, partial η2 = .002. A patient without a psychiatric
diagnosis was perceived to be more predictable (M = 68.12, SD = 20.01) than an identical
patient with depression (M = 64.45, SD = 21.41), F(1, 523) = 4.49, p = .035, partial η2 =
.009, and an identical patient with schizophrenia (M = 56.11, SD = 20.04), F(1, 522) =
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53.61, p < .001, partial η2 = .093. Further, a patient with schizophrenia was rated as less
predictable than a patient with depression, F(1, 525) = 23.62, p < .001, partial η2 = .043.
4.3.5 Desire for Social Distance
Desire for social distance varied as a function of patient behavior F(1, 785) =
232.82, p < .001, partial η2 = .229, psychiatric diagnosis, F(2, 785) = 4.73, p = .01,
partial η2 = .012, and an interaction between these two factors, F(2, 785) = 3.76, p = .02,
partial η2 = .009 (Figure 5). When the patient was calm, both a depression label (M =
23.57, SD = 23.25) and a schizophrenia label (M = 29.01, SD = 21.42) resulted in a
significantly greater desire for distance relative to no label (M = 16.76, SD = 17.27),
(depression: t(243.70) = 6.82, p = .007, partial η2 = .027; schizophrenia: t(255.80) =
12.25, p < .001, partial η2 = .091). Furthermore, a calm patient with schizophrenia
elicited a significantly greater desire for distance than an identical calm patient with
depression, t(263.52) = 5.43, p = .048, partial η2 = .015). Among irritable patients, desire
for distance was similar regardless of psychiatric status (no label: M = 48.97, SD = 29.59;
depression: M = 49.46, SD = 26.35; schizophrenia: M = 49.67, SD = 25.56), all ps > .838.
4.3.6 Does a Label Increase Social Distance Via Dangerousness and Fear?
Finally, I tested mediation models from Study 2. To accommodate a
multicategorical predictor (no mental illness label, depression, schizophrenia), dummy
codes were created with no mental illness label serving as the reference category. Model
one hypothesized that the presence of a schizophrenia diagnosis — but not a depression
diagnosis — increases perceived danger, which increases desire for social distance,
controlling for patient behavior. Model two hypothesized a serial mediation (Corrigan et
al., 2003) in which the presence of schizophrenia diagnosis — but not a depression
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diagnosis — increases perceived danger, in turn elevating fear, which predicts increased
desire for social distance, controlling for patient behavior. Mediation models were run
using Hayes’ PROCESSv3.4 in SPSS with 10,000 bootstrap samples.
Model 1. Dangerousness Mediates the Effect of a Both a Schizophrenia Label
and a Depression Label on Desire for Distance. Results were somewhat consistent with
my mediational hypotheses (Figure 6). A schizophrenia label was associated with a
significant increase in perceived dangerousness (b = 10.31, SE = 1.73, p < .001),
controlling for patient behavior. Contrary to hypotheses, a depression label was also
significantly associated with a descriptively weaker, but still significant increase in
perceived dangerousness (b = 3.56, SE = 1.73, p = .04). An increase in perceived
dangerousness was subsequently related to an increase in desire for distance (b = 0.60, SE
= 0.04, p < .001), controlling for behavior and diagnosis. As such, the model significantly
predicted desire for distance, F(4, 786) = 140.38, p < .001, R2 = .42, and the indirect
effect of a schizophrenia label on desire for distance through perceived dangerousness,
was significant (b = 6.16, SE = 1.13, bootstrapped 95% CI [4.01, 8.43]). Further,
replicating Study 2, the direct effect of a schizophrenia diagnosis on desire for distance
was no longer significant when controlling for patient behavior and this indirect effect (b
= 0.40, SE = 1.89, p = .83). Similarly, the indirect effect of a depression label on desire
for distance through perceived dangerousness, was significant (b = 2.13, SE = 1.04,
bootstrapped 95% CI [0.15, 4.23]). When interpreting the indirect effect of a depression
label on desire for distance however, it is important to note that the total effect of label on
distance (when no mediators are included in the model), was only marginally significant
(b = 3.68, SE = 2.12, p = .08). Even so, when controlling for behavior and the indirect
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effect, the direct effect of a depression diagnosis on desire for distance was weakened,
and similarly non-significant (b = 1.55, SE = 1.85 p = .40).
Model 2. Dangerousness and Fear Mediates the Effect of a Schizophrenia
Label on Desire for Distance. Again, results were somewhat consistent with my
mediation hypotheses (Figure 7). A schizophrenia label (b = 10.31, SE = 1.73, p < .001)
and a depression label (b = 3.56, SE = 1.73, p = .04) were again associated with greater
perceived dangerousness, controlling for patient behavior. Greater dangerousness was
subsequently related to greater fear (b = 0.52, SE = 0.03, p < .001), controlling for
behavior and diagnosis. Fear, in turn, was related to a significant increase in desire for
distance (b = 0.15, SE = 0.04, p < .001), controlling for all other predictors. Like Model
1, Model 2 significantly predicted desire for distance, F(5, 784) = 117.67, p < .001, R2 =
.43. The indirect effect of a schizophrenia label on desire for distance through perceived
dangerousness and fear was significant (b = 0.78, SE = 0.28, bootstrapped 95% CI [0.29,
1.38]), and when controlling for indirect effects and patient behavior, the direct effect of
a schizophrenia label on distance became non-significant (b = 1.06, SE = 1.89, p = .58).
The indirect effect of a depression label through both mediators was also significant (b =
0.27, SE = 0.16, bootstrapped 95% CI [0.01, 0.64]), and the direct effect of depression on
distance was also non-significant when controlling for indirect effects (b = 1.20, SE =
1.84, p = .51). Yet, it remains important to note that the total effect of depression on
distance was marginally significant (b = 3.68, SE = 2.12, p = .08).
4.4 Study 3 Discussion
Study 3 replicates effects of irritable behavior and a schizophrenia diagnosis on
stigma markers from Studies 1 and 2 and extends these findings to a novel psychiatric
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diagnosis — depression. Beginning with my primary outcome, desire for social distance,
my findings closely align with hypotheses (H3a). When the patient was irritable,
relatively greater distance was desired from the patient regardless of the type or presence
of a psychiatric label. When the patient was calm, however, a patient with no psychiatric
label was the least stigmatized, one with depression was moderately stigmatized, and one
with schizophrenia was most stigmatized. The effect of a label on distance was also
mediated by perceptions of dangerousness to others and fear (H3b).
Regarding attitudes and emotions, I again found that irritable behavior, relative to
calm behavior, resulted in greater blame, fear, anger, and danger to others, as well as
lower caring emotions, warmth, competence, and predictability (H1). I also found
evidence that irritable behavior increased perceptions of dangerousness to oneself (i.e.,
self-harm). Replicating previous studies, a schizophrenia diagnosis resulted in greater
stigmatizing attributions, lower competence, lower predictability, and higher ratings of
perceived dangerousness to others relative to an identical patient with no psychiatric label
(H2a). A schizophrenia label also increased perceptions of likelihood to engage in selfharm relative to no psychiatric label and was unrelated to emotions.
For depression, I found mixed support for hypotheses. A depression label, relative
to no label, resulted in greater stigmatizing attributions, lower predictability, and higher
ratings of dangerousness to oneself (H2b). However, counter to hypotheses, a depression
label did not diminish warmth and competence relative to no psychiatric label and was
positively related to dangerousness to others and participant fear. Similarly, my findings
were mixed regarding differences between stigma towards schizophrenia and depression
(H2c). Consistent with hypotheses, a patient with schizophrenia was rated less
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predictable and marginally less competent compared to a patient with depression.
However, the behavior of patients with depression and schizophrenia was seen as equally
likely to be due to substance use and a hormonal imbalance, and they were perceived to
be equally cold and equally likely to harm themselves.
Lastly, two outcomes other than social distance unexpectedly differed as a
function of both observed behavior and diagnostic label — participant anger and
perceptions of dangerousness. These interactions were not hypothesized and should be
interpreted cautiously. Anger in response to an irritable (but not calm) patient was
reduced if a schizophrenia (but not depression) label was present. It may be that patients
with schizophrenia are viewed as low in personal responsibility (Jorm et al., 1997), and
this perception of uncontrollability is theorized to reduce anger (Corrigan, 2000). This is
consistent with the fact that mental disorder attributions were more likely for patients
with schizophrenia as compared to with depression and with no diagnostic label. Second,
when the patient was calm, a depression and schizophrenia label both resulted in greater
perceived dangerousness to others relative to no label, whereas when irritable, only
schizophrenia increased perceived dangerousness. It may be that in the absence of
irritable behavior, any psychiatric label is enough to elevate perceptions of
dangerousness, even if the label is not stereotypically associated with danger (i.e.,
depression; Angermeyer & Matschinger, 2003), whereas for irritable patients, a label
only elevates perceptions of dangerousness if it is also a stereotypically dangerous label
(i.e., schizophrenia).
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CHAPTER 5
GENERAL DISCUSSION
Three studies assessed the importance of a psychiatric diagnosis and irritable
behavior in generating stigma towards a hospital patient. In line with labeling theory,
irritable behavior and a psychiatric label separately impacted attitudes and emotions, but
consistently interacted to predict desire for distance. These findings lend experimental
support to the notion that precipitants of stigmatizing behavior (i.e., attitudes and
emotions; Hinshaw, 2009) are impacted in distinct ways by labels and behaviors, but both
are important in predicting behavioral manifestations of stigma (i.e., desire for distance).
Examining the interaction of label and behavior in predicting desire for distance
sheds light on how and when specific signaling events result in stigma. In all three
studies, irritable behavior resulted in a higher desire for distance relative to calm
behavior, regardless of psychiatric status. In other words, the negative effect of irritable
behavior appears to overshadow any differences in stigma that may emerge due to a
diagnostic label. Conversely, when the patient was calm, psychiatric labels did predict
desire for distance. This is noteworthy, as it suggests that patients with psychiatric labels
may have little control over how they are perceived due to their label: they are likely to
experience stigma as a function of their mental health condition even when they behave
calmly and respectfully. If replicated among medically experienced populations (e.g.,
nurses or physicians), written labels on EHRs may be a specific pathway through which
stigma perpetuates known disparities in care for these populations (McGinty et al., 2015).
The primary mechanism through which diagnostic labels impacted stigma was via
stereotyping (e.g., associating a labelled person with other stigmatizing attributions).
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Consistently, both a schizophrenia label (Studies 1-3) and a depression label (Study 3)
elicited greater behavioral attributions to substance use and hormonal imbalance. The
effects of a diagnostic label on these stigmatizing attributions suggests that those with
psychiatric diagnoses experience stigma not only as a direct function of their label, but
also as an indirect function of other stigmatized labels, which may not be relevant to them
specifically. My findings also indicate that stigmatizing attributions are not substitutive,
but additive. Once a stereotype is activated by a stigmatizing label (e.g., schizophrenia),
other negative attributions (e.g., substance use) are activated as well, and observers infer
that these negative attributions are also relevant to the target. In this way, psychiatric
diagnoses may elicit stigma akin to “double jeopardy,” in which negative inferences that
emerge due to stereotypic associations further stigmatize labelled individuals.
On the other hand, the primary mechanism through which irritable behavior
elicited stigma was via emotions. In all three studies, irritable patients elicited greater
fear, greater anger, and diminished caring emotions. Emotions did not consistently vary
as a function of written diagnosis alone, suggesting that emotions towards those with
mental illness may be less likely to be evoked by a diagnosis and more likely to be
evoked by behavior. The only effects of the diagnostic label on participant emotions
emerged in Study 3, in which depression resulted in greater fear in response to a patient,
and schizophrenia reduced anger in response to an irritable patient. These findings are
inconsistent with prior literature, as most work suggests that disorders stereotypically
associated with danger and violence (i.e., schizophrenia; Angermeyer & Matschinger,
2003) should elicit fear. The counterintuitive finding in Study 3 may be due to the fact
that imagining interacting with a patient with depression elicits fears of “making a
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mistake” or “saying the wrong thing” in front of someone who is perceived to be
emotionally fragile. This possibility should be tested in future work. As described in
Study 3, a schizophrenia label decreased anger towards irritable patients, possibly due to
a reduction in perceived controllability. While it is important to investigate possible
reasons for a relationship between diagnostic labels and emotions, the bulk of evidence
from these studies suggest that behavior is a more potent signaling event for emotional
components of stigma than written labels.
Finding that a written diagnostic label discretely affects stereotypes, and that
observed behavior discretely affects emotions has implications for anti-stigma
interventions. Specifically, uncovering distinct mechanisms suggests that two common
types of interventions — contact and education — may reduce stigma via different
processes. Contact interventions involve participants interacting with or imagining
interacting with an outgroup member (e.g., someone with mental illness; Pettigrew &
Tropp, 2008). My findings suggest that such interventions likely target stigma that
emerges as a function of observed behavior by providing examples of real, nonthreatening behavior, thereby diminishing fear, and increasing caring. Educational
interventions provide information to contradict inaccurate stereotypes (Morgan et al.,
2018). My findings suggest this likely reduces stigma that emerges as a function of a
label alone, such as false perceptions (e.g., believing those with mental illness to be
dangerous). Considering these different mechanisms, contact and education interventions
may work best when implemented together: contact to reduce negative emotions and
education to decrease endorsement of harmful stereotypes. Testing this possibility, as
well as the long-term efficacy of such hybrid interventions is necessary.
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Finally, examining the process-based questions tested by Studies 2 and 3 provides
mixed results for Corrigan and colleagues’ (2003) hypothesized mediation models.
Centrally, dangerousness to others was found to be a consistent, key mediator of the
effect of a psychiatric label on desire for distance. This is not particularly surprising for
schizophrenia, as past work suggests the label is associated with dangerousness (Marie &
Miles, 2008). This finding is surprising for depression however, as depression is not
stereotypically associated with danger to others. It is important to note that while a
depression label does predict significantly greater dangerousness, the associated increase
in danger is much smaller (b = 3.56) than for schizophrenia (b = 10.31). Including fear as
a serial mediator only resulted in a 1% increase in the proportion of variance explained in
desire for distance (Study 2: R2 = .37; Study 3: R2 = .43) compared to dangerousness only
(Study 2: R2 = .36; Study 3: R2 = .42). While it is possible that the fear measures (e.g.,
self-reported emotions regarding a hypothetical encounter) were unable to capture true
participant emotions, this modest increase in explained variability suggests that fear,
compared to perceptions of dangerousness, may be a less important predictor of desire for
distance as a function of label. This aligns with the main finding that behavior (not label)
largely predicts elevated participant emotions.
5.1 Strengths, Limitations, and Future Directions
This work has several strengths. For one, I overcome methodological criticisms of
past work by using specific labels (i.e., schizophrenia/depression [and migraines]) and a
‘no-label’ condition (i.e., migraines only) that adequately explain irritable behavior.
Importantly, all conditions included a migraine diagnosis, so causal effects of psychiatric
label are explained by the addition of a psychiatric diagnosis and not the omission of a
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migraine diagnosis. Also, the EHR is modeled on health records used in the real world,
strengthening external validity, and Study 3 eliminates the possibility that medication
non-adherence explains the effects of written diagnosis. I also used video interactions to
manipulate behavior and employed large samples in Studies 2 and 3 to ensure adequate
power to replicate marginal effects in Study 1. Lastly, my manipulations were subtle: the
patient mildly raises her voice and speaks exasperatedly in the irritable video, and the
diagnostic label was embedded in an EHR with other medical history. As such, stigma
derived from these signals is activated by slightly irritable behavior and knowledge of a
psychiatric label.
This work is not without limitations. First, my EHR manipulation includes
clinical markers of psychiatric conditions (e.g., medications, delusions, hallucinations,
depressed mood, fatigue). This offers some strengths — real-world validity, participants
having a shared understanding of the diagnosis — but the clinical markers may confound
the effect of a diagnostic label alone. Future work should examine whether a simple, oneword manipulation of schizophrenia or depression impacts stigma to the same extent as
this clinical presentation. Additionally, although I employed video stimuli, all my data
are from self-report measures. As such, my measures may be subject to self-report biases
and participant inattention. Indeed, this may explain the absence of a label’s effect on
self-reported emotions: participants may underestimate or purposefully under-report
emotions they would feel during an encounter with a patient with schizophrenia or
depression. Future work could address this limitation by simulating real world
interactions or using physiological measures of emotional activity. I also measure
attributions, emotions, and behavioral intentions in a fixed order, which may influence
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findings regarding social distance (e.g., by priming participants to think about their
emotions).
Importantly, this work examines schizophrenia and depression only, does not vary
the patient’s visible identity (e.g., gender, race), and my samples are disproportionately
white. Future work should consider manipulating the patient’s visible identity, include
additional diagnoses, and recruit racially diverse samples to test the influence of labels
and behaviors on stigma processes for diverse populations and illnesses. Lastly, while not
my current focus, examining demographic moderators of the effect of psychiatric
diagnosis on stigma markers is needed. In supplementary analyses (Appendix C), I
explored whether theoretically important moderators — participant’s age, gender,
perceived similarity to the patient, knowledge of someone with mental illness, and one’s
own mental illness status — moderate the effects of a label on all stigma markers that
demonstrated label effects in all studies. Although I found little evidence across the
studies of any variable consistently moderating these effects, future work specifically
designed to test moderation is needed, as past work suggests that respondent age (Jorm &
Oh, 2009) and exposure to mental illness (Couture & Penn, 2003) likely play a role.
5.2 Conclusion
Stigma towards those with mental illness results in significant health disparities,
but when and why specific signaling events elicit stigma towards these groups is unclear.
Across three studies, irritable behavior, and a psychiatric diagnosis both signal mental
illness, but impart divergent effects on attitudes, emotions, and behavioral intentions.
Rather than concluding one is more consequential than the other, this work shows that
both signaling events can result in stigma, but via different attitudinal and emotional
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mechanisms. Observed irritable behavior was consistently related to blaming the patient
and eliciting negative emotional reactions (e.g., anger, un-caring attitudes), while a
diagnosis was consistently related to associating the patient with other stigmatized
identities (e.g., substance use). Future work, including anti-stigma interventions, should
consider the specificities of these stigma processes. A nuanced understanding of the
reasons and precipitating events for stigma, be it behavior or diagnosis, is helpful in
seeking to combat its ill effects.
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Table 1.
Studies 1-3: Bivariate Correlations Among Study Variables and Cronbach Alphas (in parenthesis)
Study 1 Variable
1
2
3
4
5
6
7
1. Blaming Attributions
(.76)
.21**
.16*
.23**
.22**
-.13†
.23**
2. Substance Use
—
.47**
.52**
-.01
-.10
.02
3. Hormonal Imbalance
—
.53**
.14†
-.07
.03
4. A Mental Disorder
—
.00
-.01
.12
5. Contextual Attributions
(.52)
.35**
.14†
6. Caring Emotions
(.83)
.05
7. Anger Emotions
(.84)
8. Fear Emotions
9. Desire for Distance
Study 2 Variable
1. Blaming Attributions
2. Substance Use
3. Hormonal Imbalance
4. A Mental Disorder
5. Contextual Attributions
6. Caring Emotions
7. Anger Emotions
8. Fear Emotions
9. Warmth
10. Competence
11. Dangerousness
12. Predictability
13. Desire for Distance

1
(.76)

2
.32**
—

3
.28**
.49**
—

4
.32**
.52**
.42**
—

5
.11**
-.11**
.08*
-.11**
(.59)

6
-.21**
-.27**
-.19**
-.18**
.40**
(.83)
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7
.37**
.30**
.28**
.26**
-.09*
-.56**
(.84)

8
.07
.23**
.16*
.19**
.19*
.23**
.49**
(.85)

9
.32**
.30**
.17*
.37**
.01
-.23**
.31**
.14†
(.93)

8
.24**
.38**
.39**
.32**
.04
-.34**
.74**
(.90)

9
-.42**
-.22**
-.04
-.28**
.28*
.44**
-.46**
-.17**
(.89)

10
-.30**
-.30**
-.13**
-.33**
.30**
.49**
-.40**
-.21**
.73**
(.90)

11
.27**
.55**
.44**
.49**
-.06
-.33**
.46**
.57**
-.26**
-.30**
(.92)

12
-.21**
-.35**
-.26**
-.39**
.13**
.38**
-.43**
-.41**
.43**
.42**
-.55**
(.70)

13
.37**
.36**
.22**
.37**
-.19**
-.45**
.52**
.41**
-.61**
-.51**
.52**
-.68**
(.93)

Study 3 Variable
1
2
3
4
5
6
7
8
9
10
11
12
13
14
1. Blaming Attributions
(.77)
.26**
.22**
.31**
.15** -.25** .36**
.25** -.46** -.26** .30**
.28** -.24** .44**
2. Substance Use
—
.42**
.49** -.16** -.32** .30**
.34** -.35** -.33** .48**
.50** -.27** .42**
3. Hormonal Imbalance
—
.44**
.09*
-.19** .21**
.28** -.16** -.24** .34**
.35** -.19** .27**
4. A Mental Disorder
—
-.01
-.23** .28**
.33** -.30** -.32** .48**
.52** -.38** .43**
5. Contextual Attributions
(.60)
.31** -.11**
.04
.19**
.19**
-.08*
-.03
.04
-.13**
6. Caring Emotions
(.90)
-.60** -.41** .52**
.48** -.31** -.22** .31** -.48**
7. Anger Emotions
(.89)
.73** -.52** -.38** .42**
.34** -.39** .53**
8. Fear Emotions
(.89)
-.26** -.24** .50**
.45** -.37** .40**
9. Warmth
(.87)
.69** -.38** -.35** .44** -.69**
1. Competence
(.87)
-.34** -.31** .39** -.55**
11. Dangerousness to Others
(.91)
.71** -.50** .56**
12. Dangerousness to Self
(.96)
-.48** .49**
13. Predictability
(.60)
-.57**
14. Desire for Distance
(.96)
Note. Blaming Attributions: General attitude, mood, personality, having a bad day. Contextual Attributions: Stress, pain, lack of sleep. Caring Emotions:
Concerned, compassionate, sympathetic, engaged, desire to help. Angry Emotions: Angry, irritated, frustrated, upset, calm (rev.), relaxed (rev.). Fear Emotions:
Afraid, anxious, nervous, unsafe, uneasy. Warmth: Warm, friendly, good-natured, honest. Competence: Competent, intelligent, skilled, capable. Dangerousness to
Others: 2 items. Dangerousness to Self: 2 items. Predictability: 2 items. Desire for Distance: 8 items. *p < .05. **p < .01.
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Table 2.
Studies 1-3: Mean Attitudes, Emotions, and Desire for Social Distance as a Function of Patient Behavior and Mental Illness Diagnosis
Calm Patient Behavior
Outcome
Variable

n

Blaming
Attributions

No
Diagnosis

Depression

1

49

—

49

2

195

—

179

3
1

132
49.15
(21.04)
47.65
(22.01)
45.68
(22.06)
14.30
(20.46)
19.13
(22.78)
13.40
(18.08)
23.28
(25.56)
27.51
(24.74)
20.52
(20.65)
17.56
(22.67)
19.47
(23.16)
13.42
(16.75)

133
—

135
46.83
(19.72)
47.06
(20.70)
47.14
(21.33)
29.45
(24.93)
26.69
(25.98)
20.77
(22.98)
36.75
(24.85)
31.17
(26.59)
27.67
(24.69)
53.18
(26.80)
46.50
(28.64)
41.99
(28.74)

400
48.00
(20.32)
47.37
(21.37)
47.02
(20.99)
21.96
(23.95)
22.75
(24.62)
19.59
(23.42)
29.95
(25.98)
29.27
(25.67)
26.17
(24.45)
35.19
(30.48)
32.41
(29.21)
30.39
(27.64)

Study

2
3
Substance Use

1
2
3

Hormonal
Imbalance

1
2
3

A Mental
Disorder

1
2
3

—
48.22
(19.58)
—
—
24.53
(27.06)
—
—
30.25
(26.72)
—
—
35.49
(27.20)

Schizophrenia

Irritable Patient Behavior
No
Diagnosis

Depression

98

48

—

49

374

191

—

184

130
68.40
(13.28)
62.93
(20.33)
66.21
(20.45)
18.63
(20.53)
23.68
(26.11)
24.92
(26.66)
27.06
(27.24)
26.63
(26.05)
29.63
(27.32)
25.29
(25.95)
24.53
(26.11)
25.77
(25.85)

132
—

129
64.28
(14.99)
62.91
(19.10)
64.35
(20.89)
22.99
(22.73)
32.18
(27.51)
27.35
(25.94)
31.60
(26.27)
35.00
(26.18)
31.72
(27.75)
59.23
(29.48)
55.48
(27.82)
54.50
(29.76)

391
66.32
(14.25)
62.92
(19.71)
65.97
(19.69)
20.83
(21.67)
27.85
(27.10)
26.98
(27.08)
29.35
(26.71)
30.74
(26.41)
31.08
(27.21)
42.43
(32.48)
39.72
(31.07)
41.77
(31.05)

Total
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—
67.33
(17.64)
—
—
28.63
(28.62)
—
—
31.87
(26.71)
—
—
45.10
(30.36)

Schizophrenia

Total
No
Diagnosis

Depression

97

97

375

386
262
58.68
(20.03)
55.21
(22.51)
55.87
(23.59)
16.47
(20.50)
21.38
(24.56)
19.12
(23.42)
25.13
(26.33)
27.07
(25.37)
25.04
(24.57)
21.34
(24.51)
21.97
(24.76)
19.55
(22.57)

Total

Schizophrenia

Total

—

98

195

—

363

749

265
—

264
55.65
(19.48)
55.10
(21.40)
55.55
(22.77)
26.22
(23.95)
29.47
(26.87)
23.99
(24.65)
34.18
(25.57)
33.11
(26.41)
31.06
(26.68)
56.20
(28.19)
51.05
(28.54)
48.10
(29.85)

791
57.16
(19.77)
55.16
(21.96)
56.39
(22.44)
21.39
(22.79)
25.30
(26.00)
23.24
(25.55)
29.65
(26.28)
30.00
(26.04)
28.59
(25.95)
38.77
(31.61)
36.07
(30.35)
36.02
(29.90)

—
57.74
(20.92)
—
—
26.58
(27.87)
—
—
31.06
(26.68)
—
—
40.29
(29.17)

Calm Patient Behavior
Outcome
Variable

Contextual
Attributions

Study

1
2
3

Caring
Emotions

1
2
3

Anger Emotions

1
2
3

Fear Emotions

1
2
3

Desire for
Distance

1
2
3

No
Diagnosis

69.40
(17.33)
68.74
(17.13)
65.37
(16.83)
65.69
(19.49)
75.57
(19.27)
78.01
(16.27)
33.26
(20.50)
25.96
(18.81)
21.32
(16.96)
19.56
(19.58)
21.55
(21.86)
15.17
(18.60)
29.85
(20.69)
21.92
(21.57)
16.76
(17.27)

Depression

—
—
66.31
(17.92)
—
—
75.56
(19.64)
—
—
26.34
(20.00)
—
—
21.96
(23.08)
—
—
23.57
(23.25)

Irritable Patient Behavior

Schizophrenia

Total

No
Diagnosis

69.30
(16.07)
63.12
(17.66)
65.28
(16.68)
64.49
(19.74)
75.47
(18.68)
78.57
(18.67)
28.93
(17.80)
23.88
(20.32)
22.49
(15.22)
19.94
(19.72)
20.58
(22.96)
17.43
(18.83)
44.08
(19.87)
32.55
(21.98)
29.01
(21.42)

69.35
(16.63)
66.05
(17.59)
65.65
(17.11)
65.09
(19.52)
75.52
(18.97)
77.38
(18.26)
31.12
(19.23)
24.96
(19.55)
23.38
(17.59)
19.76
(19.55)
21.09
(22.36)
18.19
(20.42)
36.96
(21.41)
27.01
(22.38)
23.16
(21.36)

73.35
(18.53)
66.67
(20.79)
64.52
(20.93)
56.29
(23.91)
65.22
(24.43)
62.65
(23.79)
44.99
(22.55)
46.26
(25.52)
49.26
(22.85)
17.93
(19.43)
29.04
(23.06)
29.65
(22.24)
53.95
(20.95)
46.98
(27.27)
48.97
(29.59)
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Depression

—
—
66.90
(21.30)
—
—
66.50
(23.76)
—
—
47.34
(22.59)
—
—
31.23
(23.25)
—
—
49.46
(26.35)

Total

Schizophrenia

Total

No
Diagnosis

70.60
(11.09)
62.39
(17.05)
63.08
(18.12)
60.50
(19.02)
67.00
(22.02)
68.26
(20.56)
48.80
(21.75)
45.19
(21.21)
40.80
(23.08)
23.94
(19.12)
32.22
(22.99)
26.80
(22.42)
51.21
(23.50)
51.31
(26.25)
49.67
(25.56)

71.96
(15.21)
64.57
(19.14)
64.85
(20.19)
58.40
(21.59)
66.09
(23.27)
65.80
(22.83)
46.89
(22.12)
45.74
(23.48)
45.82
(23.07)
20.97
(19.41)
30.60
(23.05)
29.25
(22.66)
52.57
(22.20)
49.10
(26.82)
49.36
(27.15)

71.35
(17.95)
67.72
(19.03)
64.94
(18.94)
60.99
(22.20)
70.45
(22.55)
70.39
(21.72)
39.12
(22.23)
36.00
(24.56)
35.19
(24.46)
18.74
(19.42)
25.26
(22.74)
22.36
(21.70)
41.78
(23.99)
34.32
(27.54)
32.74
(29.03)

Depression

—
—
66.61
(19.64)
—
—
71.05
(22.22)
—
—
36.80
(23.74)
—
—
26.58
(23.58)
—
—
36.47
(27.98)

Schizophrenia

Total

69.95
(13.75)
62.75
(17.33)
64.20
(17.40)
62.50
(19.39)
71.18
(20.85)
73.51
(20.26)
38.97
(22.17)
34.69
(23.33)
31.47
(21.49)
21.94
(19.42)
26.48
(23.67)
22.02
(21.16)
47.64
(21.95)
42.06
(25.96)
39.10
(25.66)

70.65
(15.95)
65.31
(18.38)
65.25
(18.69)
61.74
(20.80)
70.80
(21.73)
71.65
(21.43)
39.05
(22.14)
35.36
(23.96)
34.49
(23.35)
20.37
(19.44)
25.85
(23.19)
23.66
(22.24)
44.72
(23.12)
38.07
(27.05)
36.11
(27.68)

Calm Patient Behavior
Outcome
Variable

Warmth

Study

No
Diagnosis

1
2
3

Competence

1
2
3

Perceived
Predictability

1
2
3

Perceived
Danger to
Others

1
2

Depression

Total

—

—

—

—

—

66.50
(18.67)
67.40
(15.55)
—

—

64.06
(17.07)
63.46
(17.42)
—

65.33
(17.94)
64.24
(17.38)
—

41.19
(22.29)
37.94
(18.24)
—

65.19
(16.26)
64.34
(15.51)
—

67.82
(16.42)
66.90
(15.62)
—

58.48
(19.31)
57.88
(17.52)
—

62.84
(19.95)
61.63
(18.15)
—

68.30
(20.21)
69.00
(18.50)
—

62.06
(21.65)
60.59
(20.31)
—

15.87
(19.47)
11.90
(16.83)
—

20.15
(20.49)
20.32
(22.43)
—

70.24
(16.23)
69.90
(14.39)
—
73.30
(19.18)
75.54
(16.72)
—

61.89
(18.66)
—
—
66.51
(16.50)
—
—
69.98
(17.99)
—
—

No
Diagnosis Depression

Schizophrenia

—
—

Total
Total

No
Diagnosis

Depression

Schizophrenia

Total

—

—

—

—

—

—

38.27
(19.40)
39.48
(17.58)
—

39.76
(20.94)
38.06
(17.98)
—

53.98
(24.11)
52.78
(22.44)
—

—

50.99
(22.36)
51.74
(21.20)
—

52.53
(23.31)
51.30
(21.99)
—

54.07
(18.23)
54.95
(17.57)
—

56.32
(18.89)
56.97
(17.25)
—

64.42
(18.75)
63.93
(17.09)
—

59.55
(18.14)
59.74
(17.18)
—

62.06
(18.60)
61.99
(17.17)
—

50.99
(21.94)
50.32
(20.37)
—

56.63
(22.46)
56.62
(21.74)
—

67.74
(21.17)
68.12
(20.01)
—

56.83
(21.78)
56.11
(20.04)
—

62.45
(22.14)
62.88
(21.08)
—

20.76
(22.86)
—

31.83
(25.34)
31.59
(23.02)
—

25.88
(23.70)
24.19
(23.30)
—

16.13
(19.99)
13.36
(19.40)
—

16.95
(20.83)
—

25.94
(23.40)
23.57
(22.04)
—

20.88
(22.24)
17.97
(21.19)
—

36.80
(18.16)
—
—
58.05
(16.61)
—
—
58.88
(23.14)
—
—

49.39
(22.26)
—
—
62.29
(17.06)
—
—
64.45
(21.41)
—
—

1

12.18
(18.72)
6.50
(12.60)
—

13.17
(17.89)
—

19.90
(19.51)
15.92
(18.05)
—

2

—

—

—

—

—

—

—

—

—

—

—

—

3

10.88
(15.84)

25.47
(23.17)

30.29
(22.20)

22.28
(22.22)

23.07
(23.08)

30.88
(26.09)

40.92
(24.96)

31.60
(25.74)

16.93
(20.65)

28.16
(24.77)

35.49
(24.14)

26.88
(24.45)

3
Perceived
Danger to Self

Irritable Patient Behavior

Schizophrenia

Note. Standard Deviations in parentheses. All responses provided on unnumbered sliding scales scored 0-100. Study 1 includes 195 college students.
Study 2 (n = 749) and Study 3 (n = 791) employed MTurk samples.
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Figure 1.
Studies 1 and 2: Desire for Social Distance from a Hospital Patient as a Function of Patient
Behavior and Schizophrenia Diagnosis

Desire For Social Distance From Patient
0 = No distance, 100 = Maximum distance

70
60
50
40
30
20
10
0

No Mental Illness

Schizophrenia

No Mental Illness

Study 1

Schizophrenia

Study 2

Calm Behavior

Irritable Behavior

Note. In study 1 (n = 195 undergraduate students), desire for social distance from the calm/no
mental illness patient is significantly lower than desire for distance from all three other
conditions, p < .01, which do not differ from one another, p > .30. In study 2 (n = 749 Mturk
participants), all conditions are significantly different from one another, p < .01, except the
irritable/no mental illness condition and the irritable/schizophrenia condition, which do not differ
from one another, p = .32. Error bars = +/- 1 SE.
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Figure 2.
Study 2: Single and Serial Mediation Models of Perceived Dangerousness and Fear Mediating
the Effect of a Schizophrenia Diagnosis on Desire for Social Distance

Note. Both mediation models control for patient behavior. Unstandardized regression coefficients
are presented with 95% confidence intervals. In the single mediation model (Model 1), indirect
(a*b), total (c), and direct (c’) effects are presented in the diagram. In the serial mediation model
(Model 2), the indirect effect through perceived dangerousness only is 4.28 [95% C.I. 2.71,
6.07], the indirect effect through fearful emotions only is -0.75 [95% C.I. -1.45, -0.25], and the
indirect effect through both dangerousness and fear is 0.93 [95% C.I. 0.39, 1.66].
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Figure 3.

Angry Emotions Towards the Patient
0 = No Anger At All, 100 = Maximum Anger

Study 3: Participants’ Self-Reported Anger Towards a Hospital Patient as a Function of Patient
Behavior and Psychiatric Diagnosis
**
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Schizophrenia Label

Irritable Behavior

Note. n = 791 Mturk participants. Angry Emotions: Angry, irritated, frustrated, upset, calm
(reversed), relaxed (reversed) (α = .89). Among irritable patients, a schizophrenia label results in
reduced anger relative to no label (p = .003), whereas among calm patients, a schizophrenia label
does not reduce anger (p = .56). ** = p < .01. Error bars = +/- 1 SE.
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Figure 4.
Study 3: Perceived Dangerousness of a Hospital Patient as a Function of Patient Behavior and
Psychiatric Diagnosis
Percieved Dangerousness of Patient
0 = Not Dangerous at All, 100 = Very Dangerous
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Note. n = 791 Mturk participants. Among irritable patients, the schizophrenia patient is rated as
significantly more dangerous than both the no mental illness label patient (p < .001) and the
depression patient (p < .001), which do not differ from each other (p = .88). Among calm
patients, the no mental illness label patient is rated as significantly less dangerous than the
depression patient (p = .001) and the schizophrenia patient (p < .001) which do not differ from
each other (p = .21). ** = p < .01. Error bars = +/- 1 SE.
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Figure 5.
Study 3: Desire for Social Distance from a Hospital Patient as a Function of Patient Behavior
and Psychiatric Diagnosis

Desire For Social Distance From Patient
0 = No distance, 100 = Maximum distance
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Note. n = 791 Mturk participants. All calm behavior conditions differ significantly from all
irritable behavior conditions, ps < .001. Desire for social distance from the calm/no mental
illness label condition is significantly lower than both the calm/depression condition (p = .007)
and the calm/schizophrenia condition (p < .001) which also differ significantly from one another
(p = .048). Irritable behavior conditions are all statistically similar to one another, ps > .838.
* = p < .05. ** = p < .01. Error bars = +/- 1 SE.
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Figure 6.
Study 3: Single Mediation Model of Perceived Dangerousness Mediating the Effect of Specific
Psychiatric Diagnoses on Desire for Social Distance

Note. Mediation model is controlling for patient behavior. Unstandardized regression coefficients
are presented with 95% confidence intervals. Indirect (a*b), total (c), and direct (c’) effects are
presented in the diagram. The indirect effect of label through perceived dangerousness on desire
for distance is significant for both schizophrenia and depression.
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Figure 7.
Study 3: Serial Mediation Model of Perceived Dangerousness and Fear Mediating the Effect of
Specific Psychiatric Diagnoses on Desire for Social Distance

Note. Mediation model is controlling for patient behavior. Unstandardized regression coefficients
are presented with 95% confidence intervals. Relative total (c), and direct (c’) effects for each
dummy coded diagnostic label are presented in the diagram. Relative indirect effects of dummy
coded diagnostic labels through mediators are presented in list form.
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Appendix A
Study Materials
No Mental Illness Label Condition (Studies 1 and 2)
In the no mental illness label condition for Studies 1 and 2, this written
description of the patient appeared directly above the electronic health record (EHR):
“Jill Buckley is a 22-year-old student who has come into her doctor's office complaining
of a severe headache. She was diagnosed in 2015 with migraines and has been
hospitalized twice over the last three years. She takes medication for this illness, but
sometimes becomes upset due to the pain.” Figure S1 is the EHR used in the no mental
illness label condition.
Figure S1.
Studies 1 and 2: No Mental Illness Electronic Health Record
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Schizophrenia Label Condition (Studies 1 and 2)
In the schizophrenia label condition for Studies 1 and 2, this written description of
the patient appeared directly above the EHR: “Jill Buckley is a 22-year-old student who
has come into her doctor's office complaining of a severe headache. She was diagnosed in
2015 with migraines and 2016 with schizophrenia, and has been hospitalized twice over
the last three years. She takes medication for these illnesses, but sometimes hears voices
and becomes upset due to the pain.” Figure S2 is the EHR used in the schizophrenia label
condition for Studies 1 and 2.
Figure S2.
Studies 1 and 2: Schizophrenia Electronic Health Record
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No Mental Illness Label Condition (Study 3)
In the no mental illness label condition for Study 3, this written description of the
patient appeared directly above the EHR: “Jill Buckley is a 22-year-old student who has
come into the hospital complaining of a severe headache. She was diagnosed in 2017
with migraines and has been hospitalized twice over the last three years. She takes
medication for this illness, but sometimes becomes upset due to the pain.” Figure S3 is
the EHR used in the no mental illness label condition for Study 3.
Figure S3.
Study 3: No Mental Illness Label Electronic Health Record
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Schizophrenia Label Condition (Study 3)
In the schizophrenia label condition for Study 3, this written description of the
patient appeared directly above the EHR: “Jill Buckley is a 22-year-old student who has
come into the hospital complaining of a severe headache. She was diagnosed in 2017
with migraines and 2018 with schizophrenia, and has been hospitalized twice over the
last three years. She takes medication for these illnesses, but sometimes hears voices and
becomes upset due to the pain.” Figure S4 is the EHR used in the schizophrenia label
condition for Study 3.
Figure S4.
Study 3: Schizophrenia Label Electronic Health Record
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Depression Label Condition (Study 3)
In the depression label condition for Study 3, this written description of the
patient appeared directly above the EHR: “Jill Buckley is a 22-year-old student who has
come into the hospital complaining of a severe headache. She was diagnosed in 2017
with migraines and 2018 with depression, and has been hospitalized twice over the last
three years. She takes medication for these illnesses, but sometimes has a depressed
mood and becomes upset due to the pain.” Figure S5 is the EHR used in the
schizophrenia label condition for Study 3.
Figure S5.
Study 3: Depression Label Electronic Health Record
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Table S1.
Studies 1-3: Video Stimuli Transcripts
Calm Patient Script (60 seconds)
Physician: Hi, good afternoon Ms.
Buckley. I’m Dr. Campbell. What brings
you to the emergency department today?
Patient: I just, uh, I have a really bad
migraine. It’s lasted about 9 days. Um,
I’ve had migraines in the past but it’s
never lasted this long and I’m really tired.
Physician: Can you describe for me this
headache in more detail?

Irritable Patient Script (62 seconds)
Physician: Hi there Ms. Buckley. I’m Dr.
Campbell. It’s nice to meet you. What
brings you into the emergency department
today?
Patient: Finally! Um... I have a bad
migraine headache. I've had it for 9 days.
I’ve had headaches in the past but they’ve
never lasted this long and I’m getting
really tired of it.
Physician: Can you try to describe for me
this headache in more detail?

Patient: Yeah, it’s just like a pain all over
my head, like it’s being squeezed.

Patient: It’s a, it’s a bad migraine? It’s
like pain all over my head, my heads
being squeezed.

Physician: How long really have you
been feeling this way?

Physician: How long has it been feeling
like this?

Patient: Well, I woke up this morning
and it was feeling a lot worse.

Patient: It got much worse this morning
when I woke up.

Physician: Have you seen anyone for this
headache?

Physician: Have you seen anybody for
this particular headache?

Patient: Yeah, I went to the ER a few
days ago. They didn’t really do much for
me? They told me it was a migraine and
that it would go away with some time but
it hasn’t. It’s gotten a lot worse. I’ve
missed a lot of work so I don’t know if
it’s possible to get, like a note for today?

Patient: Yeah, I went to the ER a few
days ago and they basically did nothing
for me! They just told me it was a
migraine and they sent me home. They
said it would go away in time and it
hasn’t! It’s gotten much worse and I’ve
missed a ton of work so, so I’m going to
need a note.
Physician: Can you tell me if this
headache started suddenly or gradually?

Physician: Tell me a little bit more about
this headache first. Did it start suddenly or
gradually?
Patient: No it wasn’t sudden. It was
gradual.

Patient: No, it wasn’t suddenly. It wasit's been getting worse!
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Appendix B
Study Measures
Example of sliding scale instrument used to record responses in all studies:

Study 1 Measures
Attributions for Behavior
Having reviewed the patient information and watched the video, to what extent do you
think the patient's behavior with their doctor is due to___________?
1. Lack of sleep
2. Pain from the headache
3. Stress
4. Being at the hospital
5. How the doctor is treating them
6. Having a bad day
7. Her general attitude
8. Her mood
9. Her personality
10. Hormonal imbalance
11. Being too weak to deal with normal levels of pain
12. Substance use
13. A mental disorder
Note. Items were presented in a random order, all on the same page. Responses were
provided on unnumbered sliding scales that were then scored from 0 (Not at all) to 100
(Very much).
Participant Emotions
We are also interested in how you felt while you were viewing the video. Please
indicate the extent to which you experienced each of the following emotions while
watching the video.
1. Happy
2. Sad
3. Angry
4. Calm
5. Sympathetic
6. Apathetic
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7. Engaged
8. Disinterested
9. Uneasy
10. Anxious
11. Concerned
12. Compassionate
13. Afraid
14. Irritated
15. Upset
16. Frustrated
17. Nervous
18. Relaxed
19. Impatient
20. Unsafe
21. Desire to help
Note. Items were presented in a random order, all on the same page. Responses were
provided on unnumbered sliding scales that were then scored from 0 (Not at all) to 100
(Very much).
Perceived Pain and Similarity.
How much pain do you think this patient is in? 0: No pain at all, 10: Severe pain
How similar do you think you are to this patient? 0: Not similar at all, 100: Very similar

Desire for Social Distance
For the next series of questions, we are interested in your initial reaction when reading
these questions. Please respond to these questions quickly, based off your first
impression.
With what you know about this patient, how comfortable would you be…
1. knowing this person went to your school?
2. being in the same class as this person?
3. sitting next to this person in a lecture?
4. having a conversation with this person?
5. working on a group project with this person?
6. being roommates with this person?
7. having a close friend of yours date this person?
8. having a close friend of yours marry this person?
Note. Items were presented in a fixed order, on separate pages. Responses were
provided on unnumbered sliding scales ranging from 0 (Not at all comfortable) to 100
(Very comfortable).
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Study 2 Measures
Attributions for Behavior
Identical to Study 1
Warmth and Competence
To what extent do you believe this patient is ___________?
1. Warm
2. Friendly
3. Good-natured
4. Honset
5. Competent
6. Intelligent
7. Skilled
8. Capable
9. Angry
10. Calm
Note. Items were presented in a random order, all on the same page. Responses were
provided on unnumbered sliding scales that were then scored from 0 (Not at all) to 100
(Very much).
Participant Emotions
Imagine you are interacting with this patient directly. Please indicate the extent to
which you would feel the following emotions while interacting with the patient
directly.
1. Happy
2. Sad
3. Angry
4. Calm
5. Sympathetic
6. Apathetic
7. Engaged
8. Disinterested
9. Uneasy
10. Anxious
11. Concerned
12. Compassionate
13. Afraid
14. Irritated
15. Upset
16. Frustrated
17. Nervous
18. Relaxed
19. Impatient
20. Unsafe
21. Desire to help
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Note. Items were presented in a random order, all on the same page. Responses were
provided on unnumbered sliding scales that were then scored from 0 (Not at all) to 100
(Very much).

Perceived Pain, Similarity, Likeability
On a scale from 0 to 10 with 0 being no pain at all and 10 being the worst pain
imaginable, how do you think this patient might rate her pain? 0: No pain at all, 10: The
worst pain imaginable
Using the same 0 to 10 pain scale, how much pain do you believe this patient is
experiencing? 0: No pain at all, 10: The worst pain imaginable
How similar do you think you are to this patient? 0: Not similar at all, 100: Very similar
How likeable did you find this patient? 0: Not likeable at all, 100: very likeable

Perceived Dangerousness and Predictability
How dangerous do you think this patient is? 0: Not dangerous at all, 100: Very dangerous
How likely is it that this patient would do something violent towards other people? 0: Not
likely at all, 100: Very likely
How predictable do you think this patient’s behavior is? 0: Not predictable at all, 100:
Very predictable
How safe would you feel being around this patient? 0: Not safe at all, 100: Very safe
Desire for Social Distance Scale
With what you know about this patient, how comfortable would you be…
1. knowing this person lives in the same town as you?
2. working at the same company as this person?
3. sitting next to this person in a meeting?
4. having a conversation with this person?
5. working on a project with this person?
6. being roommates with this person?
7. having a close friend of yours date this person?
8. having a close friend of yours marry this person?
Note. Items were presented in a fixed order, on separate pages. Responses were
provided on unnumbered sliding scales ranging from 0 (Not at all comfortable) to 100
(Very comfortable).
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Study 3 Measures
Attributions for Behavior
Identical to Studies 1 and 2
Warmth and Competence
Identical to Study 2
Participant Emotions
Identical to Study 2
Perceived Pain, Similarity, Likeability
Identical to Study 2
Perceived Dangerousness and Predictability
Identical to Study 2
Perceived Dangerousness to Self
How dangerous do you think this patient is to herself? 0: Not dangerous at all, 100: Very
dangerous
How likely is it that this patient would do something harmful to herself? 0: Not likely at
all, 100: Very likely
Desire for Social Distance Scale
Identical to Study 2
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Appendix C
Supplemental Analyses
Attributions for Behavior Factor Analyses
Study 1
Attributions for the patient’s behavior were measured using thirteen items
developed for use in this study but inspired by previously used attribution measures
(Corrigan et al., 2003; Weiner et al., 2011). Participants were prompted: “To what extent
do you think the patient's behavior with their doctor is due to…” and were given a list of
possible attributions for their behavior presented in a random order. Participants
responded to each item using continuous unnumbered sliding scales scored from 0 (not at
all) to 100 (very much). Drawing from attribution theory (Corrigan et al., 2003), items
were hypothesized to fall into two categories: blameworthy attributions (e.g., her
personality) and contextual attributions (e.g., lack of sleep). While this factor structure
was based on existing structures, the selection of specific items was necessarily
exploratory, as I sought to include items specific to this medical context (e.g., pain from
the headache). A principal component factor analysis specifying a two-factor solution
using Varimax rotation explained 32.2% of the variance. However, a visual inspection of
a scree-plot indicated a three-factor solution would yield a significant increase in variance
explained.
A three-factor solution, explaining 40.4% of the variance and with three factors
with Eigenvalues greater than 1, was retained. The first factor consisted of: having a bad
day, her general attitude, her personality, and her mood (α = .76). These items were
averaged to create a ‘blameworthy attribution’ score, as they attribute the patient’s
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behavior to causes which are irrelevant to the patient’s symptoms and which indicate a
judgement of the patient’s character. The second factor included: a mental disorder,
substance use, and hormonal imbalance (α = .74). These items were grouped as
stigmatizing attributions but analyzed separately due to the distinct nature of these
identities. The third factor consisted of: stress, pain from the headache, and lack of sleep
(α = .52). Despite this low alpha, these attributions were averaged to produce a
‘contextual attributions’ score, as they are conceptually similar and consist of attributions
relevant to the patient’s context and symptoms. Three attributions did not significantly
load (< .35) onto a single factor: being at the hospital, how the doctor is treating them,
and being too weak to deal with normal levels of pain. While the need to drop items, and
low reliability for contextual attributions is unfortunate, this is not surprising given the
exploratory nature of this measure. Furthermore, all three contextual attributions were
conceptually similar, in that they described reasons for behavior grounded in the context
surrounding the patient’s visit (pain, stress, lack of sleep). As such, I used a 3-factor
structure (which replicated in Study 2).
Study 2
The administration and content of the attributions scale was identical to Study 1.
An exploratory factor analysis set to extract a three-factor solution, as in Study 1,
produced a structure which explained 44.1% of the variance and included three factors
with Eigenvalues greater than 1. Further, a visual inspection of a scree-plot suggested that
the three-factor structure from Study 1 was replicated in this dataset. All items from the
Study 1 subscales loaded onto their respective factors in Study 2 (all loadings > .40).
Therefore, three groupings identical to Study 1 were created by averaging participant
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responses to their items: blameworthy attributions (α = .76), stigmatizing attributions (α =
.73), and contextual attributions (α = .59).
Study 3
After having obtained evidence across two studies for the presence of three
attribution factors consisting of the same items, I examined the reliabilities of these
subscales in Study 3 (i.e., I did not conduct an additional exploratory factor analysis on
the Study 3 participant responses). The reliabilities were acceptable, and consistent with
my past studies I created subscales by averaging participant responses to blameworthy
attributions (α = .77), and contextual attributions (α = .60). Despite an acceptable alpha,
stigmatizing attributions (α = .71) were analyzed separately.
Self-Reported Emotions Factor Analyses
Study 1
Participants were prompted to indicate the extent to which they felt 21 different
emotions while watching the video. Participants responded to each emotion on
continuous unnumbered sliding scales scored from 0 (not at all) to 100 (very much).
Happy, sad, angry, and calm were presented first in a fixed order, followed by the
remaining items in a random order. Previous work suggests three categories of emotion
are particularly relevant to mental illness stigma: fear, anger, and caring emotions
(Angermeyer & Matschinger, 1997; Sadler et al., 2015). As such, emotion items taken
from previous work (Isbell et al., 2020) were hypothesized to capture these three
dimensions.
A principal component factor analysis specifying a three-factor solution with
Varimax rotation explained 45.3% of the variance and supported the presence of the three
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relevant emotion clusters. The first factor included afraid, anxious, nervous, unsafe, and
uneasy (α = .85). The second included angry, irritated, frustrated, upset, calm (reverse
scored), and relaxed (reverse scored) (α = .84). The third included desire to help,
concerned, compassionate, sympathetic, and engaged (α = .83). Subscales were produced
by averaging the items contributing to each factor, labelled ‘fear emotions,’ ‘anger
emotions,’ and ‘caring emotions’ respectively. Five items did not significantly load (<
.50) onto a single factor: happy, sad, apathetic, disinterested, and impatient. Happy and
sad were included as filler items. Disinterest, apathy, and impatience were included with
the exploratory hypothesis that these items reflected an absence of caring. However, these
items failed to load together in the EFA, either reverse-scored with the caring factor or as
their own factor, and as such were not included in the creation of subscales.
Consequently, I decided to retain the 3-factor structure, as each factor displayed
acceptable alphas, and are reflected in the literature (Angermeyer & Matschinger, 1997).
Study 2
The self-reported emotion items used in Study 2 were identical to those in Study
1, but the prompt was modified to increase participant endorsement of self-reported
emotions (e.g., “Please indicate the extent to which you would feel the following
emotions if you were to interact with the patient directly”). An EFA constrained to
extract three factors explained 59.5% of the variance and included three factors with
Eigenvalues greater than 1. This solution replicated that found in Study 1 and suggested
by prior work, namely three distinct clusters of fear, anger, and caring emotions
(Angermeyer & Matschinger, 1997; Sadler et al., 2015). As such, the same subscales
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were created for fear emotions (α = .90), anger emotions (α = .89), and caring emotions
(α = .90).
Study 3
After having obtained evidence across two studies for the presence of three
emotion factors consisting of the same items, I examined the reliabilities of these
subscales in Study 3 (i.e., I did not conduct an additional exploratory factor analysis on
the Study 3 participant responses). The reliabilities were good, and consistent with my
past studies. Therefore, I created subscales by averaging participant responses to fear (α =
.89), anger (α = .89), and caring emotions (α = .90).
Do Demographic Variables Moderate the Effect of a Mental Illness Label on Stigma
Markers?
Considering past research suggesting older adults may be more likely to express
stigma towards people with mental illness than younger adults (Jorm & Oh, 2009), and
that people who have contact with mental illness may be less likely to express stigma
than people who have not had contact with mental illness (Couture & Penn, 2003), I
examined whether the significant effects of a mental illness label on stigma markers in
my studies were moderated by a participant’s age, their self-reported exposure to people
with mental illness, and their own self-reported mental illness status. I also hypothesized
that similarity to the target patient may moderate effects of a diagnostic label, so I
assessed participant gender and perceived similarity to the patient as moderators as well.
Participant age and gender were captured using free response text boxes at the end of the
survey. Participant exposure to mental illness was captured using two yes/no questions at
the end of the survey: “Do you know anyone who has ever been diagnosed or treated for
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a mental health condition?” and “Have you ever been diagnosed or treated for a mental
health condition?” Perceived similarity (0 = not similar at all, 100 = very similar) was
captured on a continuous slider directly following felt emotion measures. Age and
perceived similarity were treated as continuous moderators, while exposure to those with
mental illness (0 = No, 1 = Yes), a participant’s own mental illness status (0 = No, 1 =
Yes), and gender (0 = Male, 1 = Female) were treated as dichotomous moderators.
To test for moderation, I used Hayes’ PROCESSv3.4 in SPSS with 10,000
bootstrap samples. For Studies 1 and 2, I used Model 1 and entered the label condition (0
= schizophrenia label absent, 1 = schizophrenia label present) as the focal predictor, one
selected variable (age, gender, knowledge of someone with a mental illness, one’s own
mental illness status, and perceived similarity) as a moderator, and the patient behavior
condition (0 = calm behavior, 1 = irritable behavior) as a covariate. For Study 3, I used
the same approach but with a dummy-coded, three level predictor (1 = no mental illness
label, 2 = depression label, 3 = schizophrenia label) with no mental illness label serving
as the reference group. This analysis approach was taken to specifically test the
possibility of these demographic variables moderating the effect of a mental illness label,
rather than the effect of irritable behavior, on stigma markers.
Study 1 Moderations
In Study 1, the age range of the college-aged participants was limited, spanning
from 18 to 28 (M = 19.92, SD = 1.55), and was therefore not assessed as a moderator.
The analyzed sample for moderation was 154 (79.0%) females and 38 (19.5%) males. 19
(9.7%) of the participants reported not knowing someone with mental illness and 176
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(90.3%) did report knowing someone with mental illness. 132 (67.7%) participants did
not have a mental illness themselves and 63 (32.3%) did report having a mental illness.
Table S2 presents the full results of moderation analyses in Study 1. No stigma
markers that displayed main effects of a schizophrenia label in Study 1 were significantly
moderated by any of the four hypothesized moderators (all ps > .14).
Table S2.
Study 1: Demographic Moderators of a Schizophrenia Label’s Effect on Stigma Markers
Moderator
Participant
Perceived
Knowing
Having a Mental
Gender
Similarity
Someone with
Illness
Mental Illness
Outcome
B
p
B
p
B
p
B
p
Substance Use
-5.17
.53
-0.003
.98
-12.20
.26
2.71
.69
Attribution
Hormonal Imbalance
Attribution

-2.08

.83

0.06

.65

-1.23

.92

5.01

.54

A Mental Disorder
Attribution

0.79

.93

0.05

.74

4.50

.73

-1.35

.87

Desire for Social
Distance

0.76

.92

0.01

.91

0.29

.98

-9.97

.14

Note. Unstandardized regression weights for the interaction between the focal predictor (patient
schizophrenia label, 0 = absent, 1 = present), and the specified moderator are presented. All
regressions control for patient behavior (0 = calm, 1 = irritable). Participant gender: 0 = Male, 1 =
Female. Knowing someone with mental illness: 0 = Does not know anyone with mental illness, 1 =
Knows someone with mental illness. Having a mental illness: 0 = Does not have a mental illness, 1
= Has a mental illness.

Study 2 Moderations
In Study 2, the mean age of the sample was 41.74 (SD = 13.31). The analyzed
sample for moderation was 446 (59.5%) females and 293 (39.1%) males. 215 (28.7%) of
the participants reported not knowing someone with mental illness and 516 (68.9%) did
report knowing someone with mental illness. 544 (72.6%) participants did not have a
mental illness themselves and 186 (24.8%) did report having a mental illness.
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Table S3 presents the full results of moderation analyses for Study 2. In Study 2,
some variables exhibited evidence of moderating the relationship between the presence of
a schizophrenia label and stigma markers, controlling for patient behavior. Of note,
reporting knowing someone with a mental illness in real life was related to a greater
positive impact of a schizophrenia label on thinking the patient is behaving due to a
mental disorder, and a greater negative impact of a schizophrenia label on thinking this
patient is predictable. Having a mental illness oneself was related to a schizophrenia label
levying greater negative effects on the patient’s perceived warmth and competence.
However, none of the hypothesized variables moderated the relationship between the
presence of a label and more than two of the nine stigma markers, and no variable
moderated the relationship between a schizophrenia label and dangerousness or desire for
distance.
Table S3.
Study 2: Demographic Moderators of a Schizophrenia Label’s Effect on Stigma Markers
Moderator
Participant
Participant
Perceived
Knowing
Having a
Gender
Age
Similarity
Someone with Mental Illness
Mental Illness
Outcome
B
p
B
p
B
p
B
p
B
p
Substance Use
-4.84
.21
0.18
.19
-0.00
.97
-3.53
.39
-4.17
.33
Attribution
Hormonal
Imbalance
Attribution
A Mental Disorder
Attribution

6.07

.12

0.28

.05

0.02

.27

3.27

.43

-3.07

.47

7.21

.07

-0.04

.77

-0.13

.06

8.84

.04

4.25

.34

Contextual
Attributions

-0.36

.90

-0.08

.46

-0.01

.91

0.31

.92

-3.74

.22

Warmth

-2.91

.32

0.00

.95

0.06

.19

-1.82

.56

-6.64

.05
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Competence

0.58

.83

-0.05

.58

-0.01

.83

-1.79

.53

-6.09

.04

Dangerousness

0.53

.87

0.13

.26

-0.01

.85

0.09

.98

-2.50

.48

Predictability

3.18

.31

-0.19

.09

0.04

.43

-6.42

.05

-3.99

.25

Desire for Social
Distance

-0.13

.97

0.14

.31

-0.01

.88

-0.17

.97

1.57

.70

Note. Unstandardized regression weights for the interaction between the focal predictor (patient
schizophrenia label, 0 = absent, 1 = present), and the specified moderator are presented. All
regressions control for patient behavior (0 = calm, 1 = irritable). Participant gender: 0 = Male, 1 =
Female. Knowing someone with mental illness: 0 = Does not know anyone with mental illness, 1 =
knows someone with mental illness. Having a mental illness: 0 = Does not have a mental illness, 1 =
Has a mental illness.

Study 3 Moderations
In Study 3, the mean age of the sample was 42.05 (SD = 13.68). The analyzed
sample for moderation was 543 (68.6%) females and 241 (30.5%) males. 169 (21.4%)
participants reported not knowing someone with mental illness and 609 (77.0%) did
report knowing someone with mental illness. 451 (57.0%) participants did not have a
mental illness themselves and 324 (41.0%) did report having a mental illness.
Tables S4 and S5 present the full results of moderation analyses for both a
schizophrenia label and a depression label in Study 3. Some variables exhibited evidence
of moderating the relationship between the presence of a schizophrenia label and stigma
markers, controlling for patient behavior. No variables moderated the relationship
between a depression label and stigma markers, controlling for patient behavior. Of note,
the moderating effects of knowing someone with a mental illness I observed in Study 2
were not significant in Study 3 (all ps > .18). Instead, I find in Study 3 that having a
mental illness label oneself appears to moderate the relationship between a label and
stigma markers. Specifically, the negative effect of a schizophrenia label on the patient’s
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perceived competence and predictability was stronger among participants who reported
having a mental illness themselves. Similarly, having a mental illness oneself was related
to a schizophrenia label levying greater positive effects on the patient’s perceived
dangerousness towards oneself and others.
Table S4.
Study 3: Demographic Moderators of a Schizophrenia Label’s Effect on Stigma Markers
Moderator
Participant
Participant
Perceived
Knowing
Having a
Gender
Age
Similarity
Someone
Mental
with Mental
Illness
Illness
Outcome
B
p
B
p
B
p
B
p
B
p
Substance Use
3.16
.51
-0.23
.16
0.03
.69
5.14
.32
2.70
.56
Attribution
Hormonal Imbalance
Attribution

5.58

.25

0.03

.87

0.05

.52

6.19

.24

4.87

.30

A Mental Disorder
Attribution

8.12

.11

-0.21

.22

-0.11

.19

-0.53

.92

6.99

.16

Competence

1.70

.58

0.08

.45

-0.06

.23

-4.44

.18

-6.22

.04

Dangerousness to
Others

5.61

.13

-0.06

.62

0.06

.35

4.51

.26

8.87

.01

Dangerousness to
Self

6.60

.12

0.04

.81

0.01

.93

3.85

.41

10.26

.01

Predictability

-1.37

.71

-0.09

.47

-0.11

.06

-2.51

.53

-7.79

.03

Desire for Social
Distance

0.05

.99

-0.02

.92

0.19

.01

0.92

.85

5.66

.20

Note. Unstandardized regression weights for the interaction between the focal predictor (patient
schizophrenia label, 0 = absent, 1 = present), and the specified moderator are presented. All
regressions control for patient behavior (0 = calm, 1 = irritable). Participant gender: 0 = Male, 1 =
Female. Knowing someone with mental illness: 0 = Does not know anyone with mental illness, 1 =
knows someone with mental illness. Having a mental illness: 0 = Does not have a mental illness, 1 =
Has a mental illness.
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Table S5.
Study 3: Demographic Moderators of a Depression Label’s Effect on Stigma Markers
Moderator
Participant
Participant
Perceived
Knowing
Gender
Age
Similarity
Someone
with Mental
Illness
Outcome
B
p
B
p
B
p
B
p
Substance Use
1.19
.80
-0.08
.61
0.03
.65
-5.86
.29
Attribution

Having a
Mental
Illness
B
0.83

p
.85

Hormonal Imbalance
Attribution

-1.64

.74

-0.01

.97

0.06

.41

-5.96

.29

-0.86

.85

A Mental Disorder
Attribution

3.79

.46

-0.28

.11

0.08

.27

-0.79

.89

2.54

.59

Competence

-1.10

.72

0.10

.33

-0.03

.54

1.94

.59

1.93

.50

Dangerousness to
Others

-4.13

.28

-0.07

.61

0.05

.37

-4.00

.36

-0.62

.86

Dangerousness to
Self

-1.39

.75

0.03

.83

-0.01

.83

0.29

.95

-2.24

.58

Predictability

1.57

.67

0.14

.28

0.01

.82

0.58

.89

-2.01

.56

Desire for Social
Distance

-3.13

.50

-0.16

.30

0.07

.27

3.21

.55

5.02

.24

Note. Unstandardized regression weights for the interaction between the focal predictor (patient
depression label, 0 = absent, 1 = present), and the specified moderator are presented. All regressions
control for patient behavior (0 = calm, 1 = irritable). Participant gender: 0 = Male, 1 = Female.
Knowing someone with mental illness: 0 = Does not know anyone with mental illness, 1 = knows
someone with mental illness. Having a mental illness: 0 = Does not have a mental illness, 1 = Has a
mental illness.

Summary
These exploratory analyses suggest no consistent evidence of moderation by any
of these five moderating variables investigated. In Study 2, knowing someone with a
mental illness moderated the effect of a schizophrenia label on two of the nine stigma
markers, suggesting some possible consistencies with prior findings (Couture & Penn,
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2003). However, these effects were not replicated in Study 3 for schizophrenia, nor did
they extend to depression. Instead, Study 3 found that having a mental illness oneself
may moderate the effect of a schizophrenia (but not depression) label on stigma markers.
The negative effects of a schizophrenia label on the patient’s perceived competence and
predictability, as well as its positive effects on perceived dangerousness to self and
others, were significantly stronger for participants who reported having a mental illness
themselves as compared to those who did not report having a mental illness. It is
important to note that this investigation is largely exploratory, not the primary focus of
the present investigation, and may be underpowered to detect some moderations (e.g., the
group sizes in Study 1 for participants who do not know someone with mental illness
were small). Furthermore, prior literature reviews of studies specifically focused on
testing these moderations do suggest these variables are important in moderating stigma
(Couture & Penn, 2003; Jorm & Oh, 2009). As such, future work that specifically sets out
to test moderation hypotheses using video vignettes is needed.
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Table S6.
Studies 1-3: Summary of Results
Descriptive Statistic/
Dependent Variable

Study 1 Effects

Study 2 Effects

Study 3 Effects

195 Undergraduate
Students

749 US MTurkers

795 US MTurkers

Data Collected

Fall 2019

Fall 2020

Fall 2021

Fear

No effects

Patient Emotion

Emotion and Label

Anger

Patient Emotion

Patient Emotion

Interaction

Caring

Patient Emotion

Patient Emotion

Patient Emotion

Blameworthy
Attributions

Patient Emotion

Patient Emotion

Patient Emotion

Substance Use
Attribution

Patient Label

Emotion and Label

Emotion and Label

Hormonal Imbalance
Attribution

Patient Label

Emotion and Label

Emotion and Label

Dangerousness to
Others

—

Emotion and Label

Interaction

Dangerousness to Self

—

—

Emotion and Label

Predictability

—

Emotion and Label

Emotion and Label

Warmth

—

Emotion and Labela

Patient Emotion

Competence

—

Emotion and Label

Emotion and Label

Interaction

Interaction

Interaction

Sample Size

Social Distance

Note. a Effect of label on warmth in Study 2 was marginal, p = .06.
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